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Despite tremendous advances in neonatal intensive care over the past 20 years,
prematurity carries a high burden of neurological morbidity lasting lifelong. The term
encephalopathy of prematurity (EoP) coined by Volpe in 2009 encompasses all aspects
of the now known effects of prematurity on the immature brain, including altered
and disturbed development as well as specific lesional hallmarks. Understanding the
way cells are damaged is crucial to design brain protective strategies, and in this
purpose, preclinical models largely contribute to improve the comprehension of the
cell death mechanisms. While neuronal cell death has been deeply investigated and
characterized in (hypoxic–ischemic) encephalopathy of the newborn at term, little is
known about the types of cell death occurring in preterm brain injury. Three main different
morphological cell death types are observed in the immature brain, specifically in models
of hypoxic–ischemic encephalopathy, namely, necrotic, apoptotic, and autophagic cell
death. Features of all three types may be present in the same dying neuron. In preterm
brain injury, description of cell death types is sparse, and cell loss primarily concerns
immature oligodendrocytes and, infrequently, neurons. In the present review, we first
shortly discuss the different main severe preterm brain injury conditions that have been
reported to involve cell death, including periventricular leucomalacia (PVL), diffuse white
matter injury (dWMI), and intraventricular hemorrhages, as well as potentially harmful
iatrogenic conditions linked to premature birth (anesthesia and caffeine therapy). Then,
we present an overview of current evidence concerning cell death in both clinical human
tissue data and preclinical models by focusing on studies investigating the presence of
cell death allowing discriminating between the types of cell death involved. We conclude
that, to improve brain protective strategies, not only apoptosis but also other cell death
(such as regulated necrotic and autophagic) pathways now need to be investigated
together in order to consider all cell death mechanisms involved in the pathogenesis of
preterm brain damage.
Keywords: autophagy, apoptosis, necrosis, neonatal, neuroprotection, autophagic cell death, periventricular
leucomalacia
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INTRODUCTION
Neurodevelopmental deficits are frequent among infants born
prematurely, particularly those born before 32 weeks of
gestational age (very preterm infants, VPT). Around 5–10% VPT
exhibit severe impairments such as cerebral palsy and cognitive
delay, which are linked frequently to cystic periventricular
leucomalacia (cPVL) and intraventricular and parenchymatous
hemorrhages grades III and IV, corresponding to the most
severe brain lesions. Around 10–15% of VPT exhibit more
moderate impairments, such as limited cognitive functions and
motoric deficits, linked morphologically to diffuse white and gray
matter lesions. Finally, around 30–40% of VPT exhibit impaired
academic achievement and behavioral disorders (Pierrat et al.,
2017), associated presumably with altered brain development,
dysmaturational disorders, and connectivity dysfunctions.
The major substrate of human preterm brain injury is the
encephalopathy of prematurity (EoP) that is characterized by gray
and white matter lesions reflecting combined acquired insults,
altered developmental trajectories, and reparative phenomena
(Kinney and Volpe, 2012). This term was quoted by Volpe
in 2009 to characterize the multiple hit hypothesis and
heterogeneous WM and GM impairments (including pre-
oligodendrocytes injury, axonal injury, thalamic injury, subplate
injury, and migrating GABAergic neuronal injury) affecting
key developmental pathways and resulting in adverse clinical
outcomes of VPT (Van’t Hooft et al., 2015; Schneider et al.,
2016; Synnes and Hicks, 2018). On one hand, EoP covers severe
brain lesions occurring after cell death such as in cPVL or
intraventricular–parenchymatous hemorrhages (IVH). However,
less severe brain lesions as in non-cystic and diffuse WM injury
(detected by advanced MRI techniques and characterized by
astrogliosis and microgliosis) are now more frequently observed
with some features of cell death. On the other hand, subtler brain
alterations can reflect disturbances of brain development or delay
in brain maturation and affect functional connectivity with no
apparent cell death (Ball et al., 2013; Gozdas et al., 2018).
The mostly studied anatomical structures involved in
preterm brain injury are the periventricular white matter
(PWM), the germinal matrix (source of most intraventricular
hemorrhages), and the subventricular zone (SVZ, source of
migrational and maturational disorders). Although there is
growing evidence of the GM involvement (cortex, thalamus,
nucleus caudatus, and deep GM injury), literature is sparser
(Kinney and Volpe, 2012). Recent studies have shown that
cortical interneurons development can be disrupted (reduced
Abbreviations: 3-MA, 3-methyladenin; ADC, apparent diffusion coefficients;
ATG, autophagy-related gene; CASP, caspase; c-CASP, cleaved caspase; cPVL,
cystic periventricular leucomalacia; CSF, cerebrospinal fluid; dWMI, diffuse white
matter injury; EM, electronic microscopy; EoP, encephalopathy of prematurity;
ER, endoplasmic reticulum; FA, fractional anisotropy; GA, gestational age;
GM, gray matter reduction; GMH, germinal matrix hemorrhage; HI, hypoxia–
ischemia; IVH, intraventricular hemorrhage; LC3, microtubule-associated protein
1 light chain 3; LPS, lipopolysaccharide; MRI, magnetic resonance imaging;
OL, oligodendrocytes; PE, phosphatidylethanolamine; PHH, post-hemorrhagic
hydrocephalus; preOL, pre-oligodendrocyte; PVL, periventricular leucomalacia;
PWM, periventricular white matter; SCWM, subcortical WM; SVZ, subventricular
zone; VPT, very preterm infants; WM, white matter; WMI, white matter injury.
number and morphological complexity) in preterm infants
with non-cystic WM injury or in inflammatory conditions
(Panda et al., 2018; Stolp et al., 2019). Moreover, constant
improvement in imaging techniques allows to study and detect
microstructural alterations not only in WM but also in GM
related to neurodevelopmental disorders (Chau et al., 2013;
Nossin-Manor et al., 2013; Kersbergen et al., 2016).
Therefore, it is mandatory to understand the underlying
pathophysiological cellular mechanisms contributing to WM
and GM damage and/or organization defects. It is now widely
recognized that events that induce an inflammatory context
sensitize preterm brain to injury (Hagberg et al., 2015). Beside
the inflammatory, vascular, and maturational factors implicated
in the origin of preterm brain injury and some of those
specific lesions, the etiology of the cellular factors and the
cell death mechanisms encountered, either during altered brain
development or in relation with specific lesions, are complex and
interrelated. Focusing only on studies using cell death markers
on pathological tissues, the present review proposes to do an
overview of what has been described so far in human autopsy
tissue and preclinical models regarding the different types of
cell death involved in preterm brain injury. We here considered
only studies using classical known and widely accepted cell death
markers allowing the discrimination between cell death types
(i.e., excluding studies reporting loss of cells without clarification
of the type of cell death involved). Therefore, according to our
selection criteria, this review will be focused mainly on the
most severe cases of preterm brain injury involving “anatomical”
evidence of brain damage.
Since EoP includes diverse causes that cannot be reproduced
in one unique model, our investigations addressed the main
pathological conditions related to EoP such as inflammation,
hypoxia–ischemia (HI)/excitotoxicity, and other cytototoxic
conditions related to current therapies such as hyperoxia,
caffeine, and anesthetics. We will then discuss the need to
investigate more in detail and improve our understanding of
the different oligodendrocyte and neuronal death pathways
that can play, even if not massive in some conditions, a role
in neurological deficits developed by both preterm humans
and animal models.
MAIN DIFFERENT TYPES OF CELL
DEATH
It is now globally accepted that three main morphological
types of cell death exist as previously proposed by Peter
Clarke in 1990 in physiological cell death conditions during
development (Clarke, 1990): type 1 or apoptosis, type 2 or
autophagic cell death, and type 3 or necrotic cell death (Figure 1).
This classification is also valid for cell death involved in
different pathologies, including brain injury. However, it has
been described that, especially in the immature brain, hybrid
morphological forms of cell death could occur in the same
dying cell, reflecting the presence of interconnections between
the molecular pathways controlling the execution of different
cell death types (Portera-Cailliau et al., 1997; Puyal et al.,
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FIGURE 1 | Morphological characteristics and most currently used markers of the three main types of cell death. Analysis of the dying cell ultrastructure is the most
reliable method to identify the cell death type. The hallmark of apoptotic cell death (or type I) is a modification of the nuclear structure with presence of chromatin
condensation and nuclear fragmentation. The cytoplasm shrinks and plasma membrane deforms until it forms apoptotic bodies that will be removed by phagocytic
cells. Molecular markers of apoptosis are caspases (mainly caspase-3) and sometimes cytochrome c (Cyc) mitochondrial release in the cytosol. As a marker of
caspase-independent apoptosis, nuclear translocation of AIF (Apoptosis-Inducing Factor) is mainly used. Pyknosis (condensation) of the nucleus shown by H&E
(hematoxylin/eosin) or Hoechst stainings is also a main feature of apoptosis. TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) is a staining
revealing DNA fragmentation used as a marker of apoptosis with caution if not complemented with a cleaved-CASP3 immunostaining. Autophagic cell death (or type
II) is mainly characterized by the presence of numerous autophagosomes (multimembrane vesicles containing intact cytoplasmic material such organelles) and
autolysosomes (electron dense structure due to material at different stage of degradation). To conclude on autophagy flux with biochemical markers, it is necessary
to study both autophagosome formation and autolysosome degradation. In autophagic cell death, both processes have to be enhanced. Autophagosome presence
is reflected by the number of LC3-positive vesicles or by LC3-II level of expression on immunoblot. When autophagic degradation activity is enhanced, vesicles
positive for lysosomal markers [such as LAMP1 (lysosomal-associated membrane protein 1) or cathepsins] are increased in number and size since autolysosomes
are larger than primary lysosomes. The decrease in p62/SQSTM1 (Sequestosome-1), an autophagosome cargo protein degraded selectively by autophagy, reveals
enhanced autophagy. In some cases, the level of autophagy-related (ATG) proteins such as BECN1 (BECLIN1/ATG6), ATG7, ATG5/ATG12, or ATG14 is increased. In
necrotic cell death (or type III), ultrastructural changes are mainly cytoplasmic with organelles and cell swelling and presence of empty vacuoles. Perinuclear space is
also dilated. Plasma membrane integrity can be finally lost, inducing a strong inflammatory response. Very few tools are available to identify necrotic cell death and
mainly indirect markers are used such as strong inflammation response or Ca2+-dependent activation of calpains [mainly suggested by the production of a 145- to
150-kDa calpain-dependent cleavage of spectrin (fodrin)]. Necroptosis type of necrosis could be investigated by RIP3/RIPK3 (Receptor-interacting
serine/threonine-protein kinase) or MLKL (mixed lineage kinase domain-like) expression and activation.
2013). The multiplicity of the cell death pathways and their
positive/negative crosstalks that depend, moreover, on the cell
type, their maturity, and the type of stress (intensity, duration,
hypoxic, ischemic, inflammatory, etc.) represent then a major
challenge for the design of neuroprotective strategies (Puyal
et al., 2013). We will do here a very brief summary of the three
main types of cell death (reviewed in Northington et al., 2011;
Puyal et al., 2013).
Apoptotic Cell Death
Since about 50 years, apoptosis is largely the best-known and
characterized form of programmed cell death, which has been
proposed to be the most important mechanism of delayed
cell death occurring in different physiological and pathological
conditions, including the developing brain. The most obvious
morphological changes occurring during apoptosis concern the
nucleus. Chromatin is compacted and the nucleus condensates,
leading to the characteristic apoptotic feature of pyknosis and
finally nuclear fragmentation. The cytoplasm is also shrunk and
plasma membrane is distorted, forming blebbs that will finally
detach and then form apoptotic bodies (Figure 1).
At the molecular level, apoptosis has been extensively
characterized and can occur through two different but
convergent pathways: the intrinsic and the extrinsic pathways
(Galluzzi et al., 2018).
The intrinsic apoptotic pathway, also called the mitochondrial
pathway of apoptosis, involves mitochondria, which represent
a reservoir of apoptotic factors (stored in the intermembrane
space of mitochondria). The balance of pro- and anti-apoptotic
proteins from the BCL2 protein family controls mitochondrial
membrane integrity. These proteins are responsive to
intracellular stress coming from mitochondria, endoplasmic
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reticulum (ER), cytoskeleton, or nucleus. Pro-apoptotic proteins
are directly (BAX and BAK) or indirectly (BAD, PUMA, BIM)
involved in mitochondrial membrane permeabilization. As
anti-apoptotic proteins, BCL2, BCL-xL, or MCL1 prevents BAX
and BAK-mediated permeabilization of the outer mitochondrial
membrane and then the release of apoptotic factors in the
cytosol. Among these factors, some, such as cytochrome c,
SMAC/Diablo, and Omi/HtrA2, activate caspase-dependent
pathways and others, such as AIF and endoG, will trigger DNA
fragmentation independently of caspases.
Caspases, which are cysteine-aspartic proteases, are the main
common effectors of both intrinsic and extrinsic apoptotic
pathways. Caspases activation is then widely considered as a gold
standard marker of apoptosis in many studies including those
on human tissues. Initiator caspases (CASP), CASP2, -8, -9, -10,
and -12, activate the executor caspases (CASP3, -6, and -7) (Riedl
and Shi, 2004), which have as substrates many essential proteins
such as structural proteins, enzymes involved in DNA repair,
or transcription factors resulting in the morphological changes
induced by apoptosis (cell shrinkage, membrane blebbing,
chromatin condensation, and DNA fragmentation).
Whereas CASP9 is involved in the intrinsic pathway of
apoptosis, CASP8 and 10 are the initiators of the extrinsic
pathway. CASP8 and -10 activations depend on the binding of
extracellular death signals (such as TNFα, FasL, and TRAIL)
on “death” receptors, resulting in the formation of a death-
inducing signaling complex (DISC) used as a platform for CASP8
autoactivation. CASP8 can then directly activate the executor
caspases (CASP3, -6, and -7). However, CASP8 can also interfere
with the intrinsic pathway of apoptosis by mediating the cleavage
of BID and then producing a truncated form of BID (tBID) able
to induce BAX anchoring to the mitochondrial membrane and
subsequent membrane permeabilization.
Finally, the executor caspases (CASP3, -6, and -7) could also
be activated by CASP12 in some ER stress conditions (oxydative
stress, unfolded protein response, etc.).
Autophagic Cell Death
Autophagic cell death is morphologically characterized by the
presence of numerous autophagosomes and autolysosomes in the
cytoplasm of the dying cells, reflecting an excessive autophagy
activity (Figures 1, 2).
Macroautophagy, the main type of autophagy (beside
microautophagy and chaperone-mediated autophagy)
(Cuervo, 2004), is a physiological intracellular catabolic
process using lysosomes for degradation. Macroautophagy
(hereafter called autophagy) consists in the engulfment of
some cytoplasmic material that has to be degraded (such as
impaired long-lived proteins and organelles), in an intermediate
compartment termed autophagosome. Autophagy can be
divided into three major steps: (1) the induction phase,
which consists in the isolation of a membrane termed the
preautophagosome; (2) the autophagosome formation, which
involves elongation, incurvation, and finally closure of the
preautophagosome, resulting in multimembrane vesicles
containing cytoplasmic material including organelles; and (3)
the autophagosome maturation, which consists in the fusion of
the autophagosome with a lysosome leading to the formation
of the functional degradative compartment of autophagy, the
autolysosome (Figure 2A).
Besides, multiple analyses are needed to characterize the
presence of autophagy (Klionsky et al., 2016), and the analysis
of the autophagosomal marker, microtubule-associated protein 1
light chain 3 (LC3), is an essential step (Figure 2A). This ATG
protein (homologue of yeast ATG8) is subject to an important
ubiquitylation-like modification resulting in LC3 conjugation
to a phosphatidylethanolamine (PE), a membrane phospholipid
that allows LC3 to be incorporated into the membrane of early
and late autophagosomes. Despite the fact that other methods
could be used (such as the gold standard electron microscopy),
an increased number of LC3-positive dots combined with an
increased lysosomal activity (e.g., monitored by p62/SQSTM1
degradation) is, in many cases, sufficient to conclude for
enhanced autophagy.
The recent discovery (since the 1990s) of more than 30
evolutionarily conserved autophagy-related (ATG) genes has
largely contributed to understand the roles of autophagy in cell
survival and death (Levine and Kroemer, 2019). Due to the
important roles of autophagy in maintaining cell homeostasis
and in cell adaptation to stress conditions (such as starvation
or pathogen invasion) (Marino et al., 2011), the existence of
a type of cell death mediated exclusively by autophagy has
long been controversial (Debnath et al., 2005; Kroemer and
Levine, 2008; Clarke and Puyal, 2012). However, it is now
accepted that in specific conditions, autophagic cell death can
occur, independently of necrosis and apoptosis, such as during
development (morphogenesis or metamorphosis) or in particular
stressful conditions (Clarke, 1990; Liu et al., 2013; Ginet et al.,
2014b) (Figures 2B,C). Despite this, pure autophagic cell death
is rarely observed, and there is now growing evidence that
autophagy-mediated cell death is more frequently involved,
meaning situations where autophagy is acting upstream of
another type of cell death (Kriel and Loos, 2019), especially
apoptosis (Grishchuk et al., 2011; Puyal et al., 2013) (Figure 2C).
Necrotic Cell Death
Necrosis (or type 3B cell death) (Clarke, 1990) is usually
considered as a passive form of cell death (unregulated and
energy-independent) occuring rapidly and irreversibly in
conditions precluding apoptotic and autophagic mechanisms
(Golstein and Kroemer, 2007). Necrosis is characterized
morphologically by the presence of dilated organelles (primarily
mitochondria and ER), the vacuolization of the cytoplasm (empty
vacuoles), and the swelling of the perinuclear space. The nucleus
is first preserved; however, it ends up also swelling as the cell
rounds up until plasma membrane ruptures (Figure 1), leading
to the release of cellular contents [including damage-associated
molecular patterns (DAMPs)] that promote and exacerbate the
inflammatory response.
More recently, programmed forms of necrotic cell deaths
have been identified, demonstrating that, in some cases,
necrotic cell death could be regulated. One of the best
characterized programmed form of necrosis is necroptosis.
Necroptosis is initiated by the activation of death receptors
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FIGURE 2 | Autophagy and autophagic cell death. (A) Schematic illustration of (macro)autophagy degradation and recycling process showing the following: (1)
isolation membrane formation from various possible intracellular membrane sources; (2) elongation and incurvation of the preautophagosome around the
cytoplasmic material that has to be degraded (proteins, organelles); (3) closure end-to-end of the preautophagosome forming the autophagosome, a
double-membrane vesicle containing undigested materials; (4) fusion of autophagosome with endosomes; (5) fusion of this amphisome with a lysosome to form a
mature autophagosome able to degrade its content (autolysosome) thanks to lysosomal hydrolases. LC3 = Microtubule-associated protein 1A/1B-light chain 3 (and
other family members). LC3 is the main marker of autophagosome. TGN = trans-Golgi network, ER = endoplasmic reticulum. (B) Electron micrographs showing CA3
neurons presenting features of autophagic cell death 24 h after perinatal hypoxia–ischemia (HI) in P7 rats (unilateral common carotid artery occlusion followed by 2 h
of hypoxia at 8% of oxygen). Dying neurons displayed both numerous multimembrane vacuoles loaded with cytoplasmic material (autophagosomes, arrow) and
electron dense vesicles containing digested material (autolysosomes, arrowhead). Note that nuclei (N) did not show chromatin condensation. Electron micrographs
of CA3 neurons from sham-operated rat brain present healthy neurons. This study was carried out in accordance with the Swiss National Institutional Guidelines for
Animal Experimentation. All experiments and methods were approved by the Veterinary Office of the Canton de Vaud. (C) Scheme illustrating the dual role of
autophagy in neurons. At basal level, autophagy maintains cellular homeostasis. A reduction or impairment of autophagy can lead to neurodegeneration (such as for
some proteinopathies). Autophagy can be activated, above its basal level, as a survival response to maintain energy level during a period of starvation, for example,
or to eliminate invading bacteria or virus. However, in other stress conditions such as excitotoxicity, enhanced autophagy could lead to cell death as a mechanism of
cell death by itself, independently of apoptosis or necrosis (autophagic cell death or type II), or as a mediator of another type of cell death, mainly apoptosis
(autophagy-mediated cell death).
(Kitanaka and Kuchino, 1999; Galluzzi et al., 2017) and is
dependent on the RIPK1/3-MLKL pathway leading to the
translocation of MLKL to intracellular and plasma membranes,
and then inducing membrane permeabilization and rupture.
ENCEPHALOPATHY OF THE
PREMATURITY IN HUMANS AND
EVIDENCE OF CELL DEATH
As mentioned in the Introduction, EoP that covers the different
injury patterns related to premature birth can affect either
the WM or GM but, depending on the nature and the
severity of the lesion, the extent of brain lesions could vary
strongly between the individuals. With new emerging MRI
techniques, better characterization of EoP now became possible
and opens new understanding, such as functional connectivity,
diffusion tensor imaging, fractional anisotropy measures and
fiber tractography, and automated segmentation techniques for
volume determination and growth (Ball et al., 2013; Gozdas
et al., 2018; Schneider et al., 2018; Duerden et al., 2019; Jakab
et al., 2019). The most prominent findings of EoP in VPT
are (1) decreased global brain volume due to white (WM)
and gray matter reduction [(GM); cortical GM as well as
deep nuclear GM], (2) hydrocephalus ex vacuo (CSF), and
(3) connectivity impairment (Dubois et al., 2008; Ball et al.,
2013; Chau et al., 2013; Kidokoro et al., 2013; Friedrichs-
Maeder et al., 2017; Gozdas et al., 2018; Duerden et al., 2019;
Jakab et al., 2019).
This new understanding facilitates the development of new
preclinical animal models, but still implementation of multiple
features of EoP seems difficult (see review from Kinney and
Volpe, 2012) and specific features of cell death in particular
models, either neuronal or glial cell death, are lacking.
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While it is widely accepted that cell death could happen in
those conditions, cell death evidence in preterm brain injury are
sparse and controversial, notably because few studies on human
preterm brain tissue have characterized and determined either
the type of cell death or, more importantly, the nature of the
dying cell type (Tables 1, 2). Another point to mention is that
in the studies claiming that cell death is not involved, not all the
different types of cell death have been investigated (most often
only apoptotic cell death markers were considered) and one can
speculate that cell death types other than apoptosis might be
involved in EoP. Finally, when comparing the different cohorts in
Tables 1, 2, it is important to keep in mind that some infants have
experienced a re-direction of care (most European countries)
whereas some infants have died reaching their natural life span
(US and Canada) and that the extent of cell death might have been
influenced by different ethical practices. Moreover, as shown in
Table 1, most of the studies were performed with cohorts from
the Boston Children’s Hospital, meaning that some data could
come from the same tissue collection.
WM Injuries and Periventricular
Leucomalacia (PVL)
The most important type of WM injury (WMI) in EoP is the
PVL (malacia: infarction and leucos: white), first described as
focal coagulative necrosis occurring in deep hemispheric WM
(Banker and Larroche, 1962). The cPVL is the most severe form
of PVL, whose incidence has decreased fivefold in the last decade
and which carries the highest burden of neurological morbidity,
especially cerebral palsy. Depending on the centers, the incidence
of cPVL is around 4–8% for the babies born before 32 weeks of
gestation and around 6 to 12% for babies born before 27 weeks of
gestation (McGowan and Vohr, 2019).
cPVL is characterized by the presence of large focal
periventricular WM necrotic lesions (necrotic foci), where all
the cells are destroyed without specificity regarding the cell
type (pan-cell death). These necrotic foci (evolving in cyst) are
surrounded by reactive glial and microglial cells localized in the
neighboring WM site where delayed cell death has been proposed
to occur. Histological observations have reported that cPVL
cases are characterized, in addition to the presence of necrotic
foci, by a massive loss not only of WM (i.e., evidenced by the
thinning of corpus callosum and subcortical WM) but also of
GM (strong volume reduction of either cortical and deep nuclear
structures). Several studies have reported increasing presence of
apoptosis (mainly evidenced by TUNEL staining and c-CASP-
3 immunohistochemistry) in cPVL in WM and GM, but few of
these studies have identified the cell type of these apoptotic dying
cells (Hargitai et al., 2001; Chamnanvanakij et al., 2002; Back
et al., 2005; Robinson et al., 2006; Pierson et al., 2007; Billiards
et al., 2008; Haynes et al., 2008; Ligam et al., 2009; Andiman et al.,
2010; Zubiaurre-Elorza et al., 2011; Buser et al., 2012; Kinney
et al., 2012; Haynes and van Leyen, 2013; Vontell et al., 2015)
(see Table 1). However, apoptosis has been reported to mediate
cell death of surrounding necrotic foci pre-oligodendrocytes
(O4+ cells) (Haynes et al., 2003; Back et al., 2005; Robinson
et al., 2006; Haynes and van Leyen, 2013), astrocytes (Gelot
et al., 2009), but also of neurons in different locations including
WM, subplate, cortex, basal ganglia, thalamus, and hippocampus
(Robinson et al., 2006; Pierson et al., 2007; Ligam et al., 2009;
Andiman et al., 2010; Kinney et al., 2012; Haynes and van
Leyen, 2013; Vontell et al., 2015). Interestingly, the density of
a type of subcortical neurons, granular neurons (GAD67/65+),
is significantly reduced not only in the periventricular and
central WM, but also in the subplate region in the presence of
PVL, suggesting that this particular subtype of neurons is more
selectively sensitive to preterm brain injury (Robinson et al.,
2006). Then, diffuse axonal injury (distant from necrotic foci) is
also observed in the WM and positive for the apoptotic marker
fractin (Haynes et al., 2008; Andiman et al., 2010; Buser et al.,
2012). This widespread axonopathy in PVL is reflecting either
secondary degeneration to GM damage (such as thalamus) or
primary alteration following a direct injury to the axon.
Focal or diffuse nondestructive lesions characterize a milder
form of WMI with an incidence up to 20 to 25% in VPT infants
(Schneider and Miller, 2019). This form is more frequently seen
in preterm neonates in recent years and has been histologically
characterized by the absence of focal necrotic lesions and the
presence of diffuse reactive astrocytes (Billiards et al., 2008;
Buser et al., 2012) and activated microglia (without macrophages
infiltration) maintained in a pro-inflammatory state (Haynes
et al., 2003; Buser et al., 2012). These observations are mostly
confirmed by human imaging studies (Kidokoro et al., 2014;
Van’t Hooft et al., 2015; Schneider et al., 2016; Synnes and Hicks,
2018), with microstructural alterations measured on advanced
magnetic resonance (MR) techniques such as diffusion-weighted
imaging (DWI) and apparent diffusion coefficients (ADC), T1
maps, and fractional anisotropy vectors (FA) and interesting
longitudinal observations.
Few studies on postmortem tissue of human preterm
suggested the absence of neuronal and cortical injury in diffuse
WMI (dWMI) (Back et al., 2005; Robinson et al., 2006; Pierson
et al., 2007) (see Table 1). Moreover, the study of Verney
et al. (2012) reported that there was no significant loss of the
number of Olig2+ oligodendrocytes in diffuse lesions (near
necrotic foci) in preterm non-cystic PWMI (Verney et al., 2012).
Their conclusion was that axonal injury could occur without
pre-oligodendrocytes death. Billiards et al. (2008) showed also
no decrease in Olig2+ cell density. However, they observed
Olig2+ cell proliferation and an increase in Olig2+ cell density
in necrotic foci and they assumed that if some loss of pre-
oligodendrocytes still occurs, it could be compensated by a
subsequent proliferation of OL progenitors (Billiards et al., 2008).
Anyway, even if pre-oligodendrocytes death did not occur, this
would not necessarily indicate that there is no cell death in
PWMI (especially in foci). Billiards et al. (2008) showed the
presence of apoptotic cells (without identifying the cell type)
in necrotic foci (microcysts) and reported also that Olig2+ cell
(that “did not appear apoptotic”) density was not affected in
periventricular necrotic foci or in the surrounding WM. The
study of the group of Charriaut-Marlangue showed that the
majority of astrocytes “in the penumbral WM” were apoptotic
(TUNEL+) in human preterm cPVL and in one case of non-
cystic PVL (Gelot et al., 2009). Regarding these two studies,
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TABLE 1 | Cell death after WMI in human preterm brain from autopsy.
Type of WMI Country (years of
sample collection)
GA PNA Pathological features Cell death
markers
+ Cell types ROIs References
Diffuse PWMI US Not indicated
PCA: 28 to 42
w
Not
indicated
↓ preOL (O4+), ↑ oxidative
stress in O4+, no cortical
neuronal loss
H&E, TUNEL
c-CASP3,
fractin IHC
O4 DWM Back et al.,
2005
Diffuse WMI CA (1983–2000) 25 to 39 w < 1 to 22
w
↓ immature OL, ↑ preOL
(O4+ O1-); ↑ GFAP, CD44
and HA; ↑ Iba-1 necrotic
foci (microcysts) 59%
↑ focal axonopathy
H&E c-CASP3
IHC
axonopathy
(β-APP, fractin)
n.d. WM Buser et al.,
2012
Diffuse WMI US (2003-2010) 22 to 42 w < 1 to 9 w ↑ GFAP, CD44 and HA;
↑ Iba-1 necrotic foci
(microcysts) 36% ↑ Olig2, ↑
focal axonopathy
H&E, c-CASP3
IHC,
axonopathy
(β-APP, fractin,
SMI-312 IHC)
n.d. WM Buser et al.,
2012
PVL
Diffuse WMI
FR -26 to 38 w
-26 w
-0 d to 2.2 w
-7 w
-cysts, ↑ Vimentin
-↑ Vimentin
TUNEL GFAP, Vimentin CTX,
PWM,SCWM
Gelot et al.,
2009
PVL US (1997–1999) 32.8 ± 3.1 w 3.7 ± 4.1 w ↑ WM and GM gliosis, focal
necrosis; ↑ neuronal loss
H&E, GFAP IHC n.d. TH, Hipp, GP,
cerebellar
nuclei
Pierson et al.,
2007
PVL United Kingdom 24 to 28.9 w 1 d to 5.1
w
↑ GFAP, ↑ Iba-1,
↓ neurons, ↑ LC3-II
LC3-II IHC n.d. TH Vontell et al.,
2015
PVL US 27 to 40 w 0 to 64 w ↑ gliosis (GFAP),
↑ CD68, ↑ protein nitration
(O4+, O1+), ↑ oxidative
stress (O4+, O1+ and
GFAP+)
Hematoxylin,
TUNEL,
Oxydative
stress
O4, O1 WM Haynes et al.,
2003
PVL US 25 to 40 w 0 to 8 w ↑12/15-LOX (O4+, O1+
and APC+) in diffuse PVL
component ↑12/15-LOX
(CD68+) in cyst
H&E, TUNEL,
Oxydative
stress
n.d. and
12/15-LOX+
WM Haynes and
van Leyen,
2013
PVL US 34.5 ± 1.1 w 7.0 ± 3.5 w Diffuse astrogliosis no
overall differences in olig2,
MBP, c-CASP3 and KI67
↑ c-CASP3 in necrotic foci
H&E c-CASP3
IHC
n.d. PWM Billiards et al.,
2008
PVL US (1993–2007) 32.5 ± 4.8 w 4.1 ± 6.6 w ↑ gliosis (GFAP),
↑ CD68, ↓ neuronal
density, ↑ axonal damage
H&E, fractin
IHC
n.d. TH Ligam et al.,
2009
PVL US 36 ± 3 w 7.5 ± 17 w ↑ gliosis (GFAP),
↑ axonopathy, ↑ GM
damage (TH31%, CTX15%)
H&E, β-APP
IHC, fractin IHC
n.d. WM, TH, CTX Haynes et al.,
2008
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one can hypothesize that astrocytes could be the apoptotic cells
described by Billiards and colleagues (2008). Another hypothesis
could be that pre-oligodendrocytes death, even if not massive, is
occurring through an apoptotic-independent mechanism, i.e., an
alternative cell death pathway.
Apart from few studies reporting the loss of pre-
oligodendrocytes (preOL) (Haynes et al., 2003; Haynes and
van Leyen, 2013), it appears that the main mechanism of the
glial dysfunction in dWMI is not due to glial cell death, but
more due to dysmaturation of the oligodendrocyte precursor
cells (PreO4+) and the imbalance and implication of “bad”
microglia (M1) and “good” (M2) microglia phenotypes (Billiards
et al., 2008; Buser et al., 2012). This disequilibrium seems to
be responsible for the dysmyelination and the gliosis observed
for instance in dWMI. Evidence of increased oxidative stress
has been reported in immature OLs in dWMI, suggesting that
oxidative stress could be a key player of the dysmaturation of OLs
supporting the formation of dWMI lesions (Haynes et al., 2003;
Billiards et al., 2008; Buser et al., 2012; Haynes and van Leyen,
2013). Multiple preclinical and clinical studies have shown that
preOL are less resistant to radical stress, certainly because of
decreased expression and function of antioxidant enzymes (such
as SOD and GN-oxidase) compared to more mature babies, such
as term or even later age (Van’t Hooft et al., 2015).
In summary, cell death is rarely reported in human
preterm WMI and PVL tissue from autopsy and cell death
characterization (co-localization of cell death and cell type
markers) is either missing or sparse.
Intraventricular and
Intraparenchymatous Hemorrhages
Severe to moderate cerebral intraventricular hemorrhage (IVH
grades III and IV or newly IPE) in preterm infants continues
to be a major clinical problem and a neurological issue,
occurring in about 5–10% of VPT. In contrast to cPVL, the
incidence of IVH has remained stable over the last decade.
Over 40% of surviving infants with IVH grade III develop
post-hemorrhagic ventricular dilatation and about one third
develop severe neurological impairment, such as cerebral palsy
and mental retardation. To date, there is only little evidence for
therapy to prevent infants from developing either hydrocephalus
or serious neurological disability in this condition. There is one
trial using a drainage and fibrinolytic approach (DRIFT Trial)
that has shown some potential benefits on the neurological
outcome, but data were inconclusive due to follow-up problems
and other methodological issues (Luyt et al., 2019). There is
also a management trial (ELVIS TRIAL) comparing early versus
late approach in lumbar tapping and rickham insertion, which
is underway (de Vries et al., 2019). It is known that blood
rapidly accumulates within the ventricles following IVH, and
this leads to disruption of normal cerebrospinal fluid flux and
can cause obstruction and increased local tissue pressure as one
of the potential etiological mechanisms (Klebe et al., 2020). As
described in Table 2, reports about preterm human data, brain
cell death, and IVH are rare, and consist in analyses of tissue from
autopsy and clinical data in preterm infants, about apoptotic and
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TABLE 2 | Cell death after IVH in human preterm brains from autopsy.
Type of
insult
Country
(years of
sample collection)
GA PNA Pathological features Cell death
markers
+ Cell
types
ROIs References
IVH DE + NL (1999–2006) 23 to 30 w 1 to 4 w ↑ sFas in CSF sFas in CSF – CSF Schmitz et al., 2011
CA 18 to 28 w 1 to 98 d ↓ KI67+ cells,
↑ apoptosis
H&E, TUNEL,
c-CASP3 IHC
n.d. GE Del Bigio, 2011
US 23 to 27 w 1 to 5 d ↑ apoptosis,
↑ microglial infiltration
(CD68+)
TUNEL,
c-CASP3 IHC,
Sytox green
n.d. GM, PVZ Georgiadis et al.,
2008
DE (1999–2001) 18 to 25 w Not indicated ↑ sFas in CSF, no
differences in sFasL and
c-CASP3
sFas and sFasL
c-CASP3 activity
– CSF Felderhoff-Mueser
et al., 2003
US (1990–1998) 26 ± 12 w Severe IVH:
6 ± 6.5 d
Mild IVH:
12 ± 5 d
↑ TUNEL (astrocytes and
OL)
H&E, TUNEL n.d. WM Chamnanvanakij
et al., 2002
HU (1993–1999) 24 to 36 w 3 d to 27 w WM disorganization
↑ karyorrhexis
H&E, TUNEL n.d. WM,
germinal
layer
Hargitai et al., 2001
CA = Canada; c-CASP = cleaved caspase; CSF cerebrospinal fluid; d = day; DE = Germany; sFas = soluble Fas; sFasL = soluble fasL; GA = gestational age at birth;
GE = ganglionic eminence; GM = gray matter; H&E = hematoxylin–eosin staining; HU = Hungary; IHC = immunohistochemistry; IVH = intraventricular hemorrhage;
n.d. = not defined; NL = Netherlands; PNA = postnatal age in weeks; PVZ = periventricular zone; ROIs = regions of interest (i.e., where cell death is detected);
US = United States; w = weeks; WM = white matter; + = positive.
necrotic markers detected in the cerebrospinal fluid (Felderhoff-
Mueser et al., 2003; Schmitz et al., 2011), in the ganglionic
eminence (Del Bigio, 2011), and in the periventricular zone
(Hargitai et al., 2001; Chamnanvanakij et al., 2002; Georgiadis
et al., 2008). However, to date, no study has systematically
investigated the involvement of the different types of cell death
and characterized the type of cell specifically affected by IVH.
Iatrogenic Preterm Brain Injury
Iatrogenic conditions involved during prematurity are
contributory factors changing the normal developmental
trajectory of the brain, notably the impact of nutrition on growth
and maturation (Beauport et al., 2017; Schneider et al., 2018)
and the use of supplemental oxygen for instance. Further, some
drugs such as caffeine as well as anesthetic and sedative drugs
might influence physiological cerebral development. In regard to
cell death types and iatrogenic factors, there are no direct reports
in human tissue associating them with cell death types and cells
involved, and only suppositions can be made based on preclinical
studies as detailed extensively further.
Hyperoxia
When leaving the hypoxic intrauterine milieu, the preterm
infant will be exposed to either diminished or excessive oxygen
saturation and variation in cerebral blood flow, which are
potentially harmful for the retina, the lung, but also the brain and
the neurodevelopmental outcome at long term [Safe Boosc (Askie
et al., 2011; Panfoli et al., 2018)]. Therefore, targeting specific
oxygen saturation, and regional cerebral oxygenation levels
through different methods such as near-infrared spectroscopy
(NIRS) are widespread in the neonatal intensive care units, and
several trials are still ongoing to confirm the detrimental effect
of hypo/hyperoxia and free radical stress in preterm brain injury
(Klebe et al., 2020). These data are supported by a tremendous
work of body on preclinical models, which are described later.
Caffeine
Caffeine therapy for the apnea of prematurity syndrome (by
stimulating the immature respiration center) is the most
widespread medication used in premature infants. Babies start
to be treated with caffeine between day of life 1 until they reach
34 weeks of corrected age and doses are relatively high (between
5 and 10 mg/kg/day 1 × daily). Clinical studies such as the
CAP Trial (Caffeine for Apnea of Prematurity) have shown a
protective effect of caffeine administrated in VPT infants, in
terms of neurodevelopmental outcome and mortality (Schmidt
et al., 2012, 2017; Panfoli et al., 2018). While the short-term
data at 18 months was slightly convincing and significant, the
effect about the neurodevelopmental outcome was ephemeral
at 5 years of follow-up. In fact, a pilot study using high-dose
caffeine therapy in premature infants showed increased cerebellar
injury and neurobehavioral deficits when compared to low dose
(McPherson et al., 2015). This controversy between preclinical
worrying and clinical reassuring data is not really rational and
raises many questions and doubts. There is probably an effect of
the dose. Therapeutical levels preventing apnea consequences in
babies are low and harmless, whereas higher doses and/or the
multiplicity of drugs combined are linked to neurotoxicity, but
this has still to be confirmed.
Anesthetics
When looking at clinical risk factors for neurodevelopmental
outcome, surgery is a major and constant contributor for
impaired neurological outcome, and these concerns are true
for neonates at term and premature infants (Sun, 2010;
Morriss et al., 2014; Sinner et al., 2014; Stolwijk et al., 2016;
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Walker et al., 2018). Premature infants may undergo several
surgical procedures such as ductus ligation, laparotomies, and
thoracotomies defined as major surgeries and herniotomies or
endoscopic laryngoscopies defined as minor surgeries. It is still
unclear whether the surgical stress, the pain perception, or
the administrated drugs for anesthesia are neurotoxic (Broad
et al., 2017; Walker et al., 2018), but the combination of
both seems to play a major role. This also explains the
development of several preclinical models in rodent and
primate animals in order to answer the unsolved questions
(Baud and Saint-Faust, 2019).
There are only very few clinical data on humans and
associated secondary effects with anesthetics/or surgery. The
group of Buonocuore measured oxidative stress (Stolwijk et al.,
2017), using non-protein bound iron (NPBI) in neonates who
underwent noncardiac surgery. These biomarkers were found
to be predictive for brain injury post-operatively. Walker
et al. (2018) in a cohort of United Kingdom Epicure in
ELBW infants found an association of neonatal surgery in
the volume of the amygdala and the somatosensory response
and pain response in young adults ex-preterm. Filan et al.
(2012) analyzed post hoc 30 babies exposed to surgery who had
more evidence of WMI and smaller brain volumes, particularly
in the deep GM. They could not find any difference in the
neurodevelopmental outcome.
The most used anesthetic drugs in premature infants are
GABA agonists such as thiopental and propofol, and NMDA
antagonists (either ketamine or anesthetic gazes such as
isoflurane or sevoflurane). Potential effects of anesthetic drugs
on the brain development are driven from the multiplicity of
preclinical studies, but very few are described on human data
(Sun, 2010; Sinner et al., 2014).
PRECLINICAL MODELS OF PRETERM
BRAIN INJURY AND EVIDENCE OF CELL
DEATH
Due to the multifactorial etiologies and the heterogeneity
of the brain pathologies involved in EoP, the challenge
was, over the last decades, to develop preclinical models
reproducing as best as possible the pathophysiology of brain
injury and/or brain development impairment observed
in the premature human brain. However, the use of a
single preclinical model of preterm brain injury cannot
reproduce exactly the human situation, and in conclusion,
each model presents advantages/disadvantages as reviewed
by others (Back et al., 2012; Kinney and Volpe, 2012;
Jantzie and Robinson, 2015).
Cell death has been investigated in preterm models in three
main species: rodent (rat and mice), sheep, and non-human
primate (macaque, baboon) (Tables 3–9). Few studies were
undertaken in rabbit and pig. Human preterm neonates are
highly exposed to WM injury between 23 and 32 weeks of
gestation that corresponds in rodents to the postnatal period
before 7 days (P1–P6), in sheep to gestational age around
95 days (90–120 days, term at 145 days), and in macaques
to gestational age 125–145 days (term at around 160 days).
Whereas substantial cell death can occur in severe models
such as those of cPVL in rodents (Table 3), the identification
of the presence of cell death frequently showed sparse cell
death in specific sites both in WM and GM affecting mainly
oligodendrocytes (OL) but also neurons. Animal models have
contributed to hypothesize that, in preterm brain injury, a
primary OL loss during the “acute” phase is followed by a
regenerative process producing immature OL that leads to
impaired myelination (Rousset et al., 2006; Segovia et al., 2008).
Neuronal injury, including not only neuronal death but also
deficits in dendrite and spine maturation (Balakrishnan et al.,
2013), could be a direct consequence of primary GM injury as
well as secondary through axonal deleterious factors linked to
primary WM injury (Rousset et al., 2006; Segovia et al., 2008;
Back and Volpe, 2018).
The need to better understand preterm brain damage at
the molecular level requires selecting the most appropriate
species, age (at which the insult is done), and type of
injury, as well as the severity of the insult according to
the precise addressed question. Preterm birth is by itself
a high-risk factor for brain injury but different deleterious
events (alone or combined) can occur and aggravate brain
development such as inflammation, hypoxia, ischemia, or
hemorrhage. Preclinical models were developed to reproduce
one or two of these factors. In the present review, we
mainly focused on studies revealing the presence of a type
of cell death in the different panels of preterm brain injury
models using cell death markers (i.e., studies using more than
classical histological observations of pyknosis and karyorrhexis
or cell counting).
Preclinical Models of Periventricular
Leucomalacia
Even if, thanks to the important progress in neonatal care, the
incidence of cPVL has considerably decreased over the past
decades, cPVL remains a major cause of cerebral palsy (Hielkema
and Hadders-Algra, 2016; Pierrat et al., 2017). Some models
were developed and found to reproduce the formation of cysts
(or necrotic foci), i.e., macroscopic areas of massive cell death
surrounded by activated microglia suggesting rapid necrotic
mechanisms (Debillon et al., 2003).
In a rat inflammatory model, intracerebral injection
of LPS formed cysts at the injection site in the corpus
callosum with TUNEL+ cells surrounding the necrotic
foci (Fan et al., 2013). Models of intrauterine infection
in rabbit and sheep have also been shown to induce the
formation of WM cysts (25–30% of survivors) accompanied
by apoptotic cell death of WM oligodendrocytes (c-CASP3+)
(Dean et al., 2009) and, in rabbit, cell death in the CA2
region of the hippocampus (TUNEL+) (Debillon et al.,
2003) (Table 3). These models showed not only that a
local strong inflammation can lead to cyst formation
but also that fetal systemic inflammation can, for some
treated animals, induce necrotic foci formation in the WM
and/or apoptotic cell death in both oligodendrocytes and
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TABLE 3 | Cell death in preclinical models of preterm white matter injury following inflammation.
Species Time of the
insult
Model Cell death
markers (time
post insult)
+ Cell types ROIs Neuroprotectant References
Sheep 91 d ga LPS (150 ng/kg),
i.v., over 3 d
c-CASP3 (7 d) n.d. SCWM hUCB cells Paton et al., 2018
93–96 d ga LPS (100 ng), i.v. TUNEL,
c-CASP3 (3 d),
Cysts (30%)
Olig2, CNPase CBWM – Dean et al., 2009
109 d ga LPS (150 ng/kg),
i.v., over 3 d
Pyknotic nuclei
(114 d ga)
n.d. PVWM hAECs Yawno et al., 2017b
5 h, 12 h, 24 h,
2 d, 4 d, 8 d, or
15 d before
preterm delivery
at 125 d ga
1 × LPS (10 mg),
intra-amniotic
c-CASP3 (2 d
to 15 d)
n.d. WM, Hipp, CX – Gussenhoven et al., 2018
Rat E17, 6 h before
preterm delivery
LPS (1 mg/kg),
maternal i.p.
c-CASP3 (6 h) n.d. n.d. Fingolimod Yavuz et al., 2017
E18 LPS (1 mg/kg),
maternal i.p.
TUNEL (E20) PDGFαR SZ NAC Paintlia et al., 2004
E18+E19
LPS (0.5 mg/kg.),
maternal i.p.,
LPS (0.3 mg/kg.),
maternal i.p.
-TUNEL,
c-CASP3 (P6)
-TUNEL,
c-CASP3 (P7)
-Impaired
autophagy (P1)
n.d.
-PVWM
-ST, PVWM, GV
-Whole brain
-APC, EPO,
SPD
–
–
Kumral et al., 2007, 2017,
Yesilirmak et al., 2007
Rousset et al., 2006
Carloni et al., 2016
P3 LPS, i.c. -(10 µg)
-(1 mg/kg)
-Fractin (4 d)
-RIP1, RIP3 and
MLKL
RNAs (1 d)
-Fractin (1 d)
-SMI-312 -ST, -ST, SCWM,
CC
-Whole
hemisphere
-CG, CC
– Ginet et al., 2016,
Lodygensky et al., 2014
Pierre et al., 2019
P3 LPS (0.25 mg/kg),
i.p.
-c-CASP3,
TUNEL (2d)
n.d. -CX, SCWM
extracts
-MSC-EVs Drommelschmidt et al.,
2017
P5 LPS (10 µg), i.c. -TUNEL (1 d)
-Cysts (30%,
injection site)
n.d. -SCWM (near
injection)
-CC
-Minocycline
–
Fan et al., 2005a
P5 LPS (2 mg/kg), i.p. TUNEL,
c-CASP3 (1 d)
O4 CG Celecoxib Fan et al., 2013
P5 IL-1β (10 ng), i.c. -TUNEL,
c-CASP3 (1d)
Lectin, O4, O1,
NF
-Sub-ventricular
area, CC, outer
layers of CTX
-NBQX Cai et al., 2004
Rabbit 24–30 d ga LPS, uterine horn,
+ ceftriaxone
(+24 h)
-TUNEL (2 d)
-Cysts
(∼25–23%)
n.d. -PVWM, CA2
-PVWM
– Debillon et al., 2003,
Debillon et al., 2000
Rhesus macaque 130 d ga, 16 h
before preterm
delivery
LPS (1 mg), i.a. c-CASP3 n.d. PVWM – Schmidt et al., 2016
APC = activated protein C; CA = cornu ammonis; CBWM = cerebellar WM; c-CASP3 = cleaved caspase-3; CNPase = 2′,3′-cyclic nucleotide 3′-phosphodiesterase;
CTX = cortex; d = day; E = embryonic day; ga = gestational age; GV = germinative ventricular zone; hAECs = human amnion epithelial cells; h = hours; Hipp = hippocampus;
i.a. = intra-amniotic; i.c. = intracerebral; i.p. = intraperitoneal; i.v. = intravenously; LPS = lipopolysaccharide; MSC-EVs = mesenchymal stem/stromal cells; NAC = N-
acetyl cysteine; n.d. = not defined; NF = neurofilament; O4, O1 = oligodendrocyte markers O4, O1; Olig2 = oligodendrocyte transcription factor; P = postnatal day;
PDGFαR = platelet-derived growth factor-α receptor; PVWM = periventricular WM; ROIs = regions of interest (i.e., where cell death is detected); SCWM = subcortical white
matter; SMI-312 = anti-neurofilament Marker (pan axonal, cocktail); SPD = surfactant protein; ST = striatum; SZ = subventricular zone; TH = thalamus; hUCB = human
umbilical cord blood; WM = white matter; nd = not defined.
neurons. Many in vitro studies strongly suggested that
activated microglia (M1 phenotype) directly contribute to
oligodendrocyte and neuron apoptotic death by releasing
reactive oxygen species or TNF-α (Dean et al., 2010;
Baburamani et al., 2014).
Beside inflammation, excitotoxicity is one of the most
common deleterious mechanisms involved in the formation of
cysts. Excitotoxicity consists in a massive intracellular increase
of calcium initiated by overactivation of excitatory amino acids
receptors (mainly glutamate) (Puyal et al., 2013). In the human
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TABLE 4 | Cell death in preclinical models of preterm brain injury following hypoxia/ischemia.
Species Time of the
insult
Model Cell death
markers (time
post insult)
+ Cell types ROIs Neuroprotectant References
Sheep 91 d ga biCCAO (45 min) -TUNEL (1 d)
-c-CASP3, fractin,
pyknotic nuclei
-O4,O1
-n.d.
-PVWM, CTX, BG
-PVWM
– Riddle et al., 2006
92 d ga - Maternal Hx
(10.5% O2,
30 min) +
brachioc. AO
(25 min)
- + 2nd Hx (+6 d)
-c-CASP3 (1 d)
pyknotic nuclei (1
d, 4 w)
-“necrotic” foci (H&E,
Iba1+)
- O4
- n.d.
-PVWM, SP
-PVWM
–
McClendon et al., 2017
Hagen et al., 2014
94–96 d ga
93–96 d ga
UCO (25 min) -TUNEL (3 d)
-cysts (∼30%)
-GFAP
-n.d.
-SCWM, PVWM, hipp,
STcn
- PVWM
-Dopa
–
Brew et al., 2016
Mallard et al., 2003
98-99 d ga UCO (25 min) -c-CASP3 (3 d)
-NeuN count (3 d)
-c-CASP3, NeuN
count (3 d)
n.d.
-STcn, STp, CA4, DG,
MN, MGN, SCWM
-STcn, CA1/2, CA3,
CA4, DG, MN
-CA3
-Epo
-Hypoth.
–
Wassink et al., 2017
Bennet et al., 2007
Dean et al., 2006
102 d ga UCO (23-25 min) -c-CASP3, TUNEL
(10 d)
-NeuN count (10 d)
-TUNEL (10 d)
n.d. -SVZ, PVWM, SCWM,
ST
-CTX
-iC
-Melatonin
–
-UCB
Yawno et al., 2017a
Li J. et al., 2017
Li et al., 2016b
125–133 d ga Partial UCO
(blood
flow < 50%,
60 min)
-TUNEL (+3 h)
-Necrotic-like
neurons (H&E,
Nissl) (0 h, 3 h),
-TUNEL (3 h)
-Annexin V and PI
(0 h, 3 h)
n.d.
-CTX, Hipp, BG, CB, BS
-CB, pons, BG,
mesencephalon
-CTX, CB, Pons
-CTX, CB, HTH, TH,
Hipp
-WIN 55, 212-2
–
Alonso-Alconada et al.,
2010
Goni-de-Cerio et al.,
2007
132 d ga UCO (10 min) -“Necrotic”/
pyknotic cells (H&E)
(1 d),
-c-CASP3 (1 d)
n.d. CC, PVWM, eC, CTX,
SVZ
– Castillo-Melendez et al.,
2013
Rat E5–E19 Maternal Hx
(10% O2)
-Cysts (H&E), TUNEL
(P0, P5)
n.d. SCWM – Fontaine et al., 2008
E18 - Uterine AsO
(60 min)
(45 min)
-TUNEL (P2)
-c-CASP3 (P5, P9)
-c-CASP3 (P2, P9)
-NeuN
-n.d.
-NeuN,
O4,O1,PDGFαR
-SPN
-PVWM
-CTX, PVWM
-EPO
-EPO
–
Jantzie et al., 2015a
Mazur et al., 2010
Robinson et al., 2005
E21 Uterine horn
blood supply
Occ (10 or
15 min)
TUNEL,
c-CASP3 (1 d)
n.d. -Hipp, CTX – Huang et al., 2013
P1 100% N2
(25 min)
-TUNEL (1 d)
-FJB (1 d)
-Necrosis,↑
autophagy
n.d. -CA1, DG
-CA2, CA3
-hipp
–
–
–
Takada et al., 2015;
Ikebara et al., 2017
P1–P2 UniCCAO+6%O2
- (3 h)
- (1.5 h–2 h)
-ISEL staining (12 h,
1 d)
-c-CASP3 (1 d)
n.d. - SP, IZ, SVZ, neoCTX,
TH
-CTX
–
–
McQuillen et al., 2003
Okusa et al., 2014
P3 UniCCAO+6%O2
- (30 min)
- (3.5 h)
-c-CASP3, fractin (1
d)
-c-CASP3 (4 d)
-n.d.
-O4
-CTX
-SCWM
-Lf
–
van de Looij et al., 2014
Segovia et al., 2008
P6 uniCCAO+
6%O2 (1 h)
TUNEL (1 d) n.d. periCCWM MgSO4 (-30 min) Seyama et al., 2018
(Continued)
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TABLE 4 | Continued
Species Time of the insult Model Cell death
markers (time post
insult)
+ Cell types ROIs Neuroprotectant References
Mouse P3–P11 10.5% O2, for 8 d -c-CASP3, PI (P11,
P15, P18)
Olig, CC1 -CC, CG, eC – Jablonska et al.,
2012; Scafidi et al.,
2014
P2–P3 UniCCAO+6%O2
(30 min)
TUNEL (1 d) n.d. CTX Hypoth. Kida et al., 2013
Pig 35/60 d ga 7% O2 (1 h) BAD, BAX n.d. CTX – Abedin et al., 2005
Rabbit E22/E25 Uterine ischemia
(40 min)
-TUNEL (1 d)
-c-CASP3 (1 d)
-n.d.
-NeuN, Ctip2
-CTX, BG, TH, CXP,
STp, SCWM
-CTX, Hipp, ST, TH
–
–
Derrick et al., 2004;
Buser et al., 2010
AO = artery occlusion; biCCAO = bilateral carotid artery occlusion; brachioc = brachiocephalic; BS = brainstem; BG = basal ganglia; CB = cerebellum; CBWM = cerebellar
WM; CC = corpus callosum; c-CASP3 = cleaved caspase-3; CG = cingulum; CTX = cortex; CxP = cortical plate; d = day; DG = dentate gyrus; Dopa = dopamine;
E = embryonic day; eC = external capsule; EPO = erythropoietin; ga = gestational age; GV = germinative ventricular zone; h = hours; H&E = hematoxylin–eosin staining,
Hipp = hippocampus; HTH = hypothalamus; Hypoth. = hypothermia; Hx = hypoxia; iC = internal capsule; i.c. = intracerebral; i.p. = intraperitoneal; i.v. = intravenous;
IZ = intermediate zone; Lf = lactoferrin; LPS = lipopolysaccharide; MGN = medial geniculate nucleus; MN = thalamic medial nucleus; n.d. = not defined; O = occlusion;
P = postnatal day; periCCWM = pericallosal white matter; PI = propidium iodide; PVWM = periventricular WM; ROIs = regions of interest (i.e., where cell death is detected);
SCWM = subcortical white matter; SP = subplate; SPN = subplate neurons; ST = striatum; STcn = striatal caudate nucleus; STp = striatal putamen; SZ = subventricular
zone; TH = thalamus; UCO = umbilical cord occlusion; uniCCAO = unilateral Common Carotid Artery Occlusion; w = weeks.
TABLE 5 | Cell death in preclinical models of preterm LPS-sensitized HI brain injury.
Species Time of the insult Model Cell death markers
(time post insult)
+ Cell types ROIs Neuroprotectant References
Mouse P2 LPS (0.05 µg/kg, -3 h),
i.p. + uniCCAO +
6.5% O2 (90 min)
c-CASP3 (1 d) O4, RECA SCWM JNK inhibition Wang et al., 2010, 2012
P3 LPS (0.05 µg/kg, -2 h),
i.p + uniCCAO + 8%
O2 (20 min)
TUNEL, c-CASP3 (1 d) n.d. CTX PINK1 KO Zhu et al., 2016
c-CASP3 = cleaved caspase-3; CTX = cortex; d = day; h = hours; i.p. = intraperitoneal; LPS = lipopolysaccharide; P = postnatal day; ROIs = regions of interest (i.e.,
where cell death is detected); SCWM = subcortical white matter; uniCCAO = unilateral Common Carotid Artery Occlusion; w = weeks.
preterm brain, the expression of N-methyl-D-aspartate (NMDA)
glutamate receptors peaks in pre-oligodendrocytes, allowing
the WM to be particularly vulnerable to excitotoxic insult
(Jantzie et al., 2015b). Then, the model using intracerebral
injection of the glutamate receptor agonist ibotenate (Table 6)
has been widely used to reproduce some aspects of human
preterm PVL, including WM cyst formation, ventriculomegaly,
reduction in brain structure volume, and decrease of WM
thickness and myelination (Descloux et al., 2018). Previous
studies showed that ibotenate-induced excitotoxicity triggers an
important inflammatory response involved in cyst formation
(Tahraoui et al., 2001; Dommergues et al., 2003). Concerning
cell death type, compiling evidence suggested that apoptosis is
importantly involved in this model. One study mentioned the
presence of c-CASP3+-positive cells in WM (Neubauer et al.,
2016). Neurodegeneration of cortical neurons has also been
demonstrated by Fluoro-Jade staining and evidence suggested
that caspase-dependent (CASP3) and -independent apoptotic
mechanisms (AIF nuclear translocation) were implicated in
cortical damage without performing, in most of the studies, an
identification of the type of dying cells. Astrocytic cell death
has been reported to occur in the site of ibotenate injection
(Tahraoui et al., 2001). More recently, we have shown that
cortical neurons [(RBFOX3)/NeuN+] presented both activation
of CASP3 and nucleus fragmentation (Descloux et al., 2018).
Moreover, we have clearly demonstrated that apoptotic neurons
displayed mixed morphological features of apoptosis (chromatin
condensation) and intense autophagy (increased presence of
autophagosomes and autolysosomes). Ibotenate increased both
the number of autophagosomes (increased LC3-II and LC3+
dots) and autophagic degradation [p62/SQSTM1 reduction and
increased number of autolysosomes (LAMP1- and CATHEPSIN
B+ vesicles)]. Inhibition of autophagy with 3-methyladenin (3-
MA) prevented CASP3 activation, suggesting a role of autophagy
upstream of apoptosis as previously shown in other models
(Puyal et al., 2009; Grishchuk et al., 2011; Xie et al., 2016).
Interestingly, 3-MA afforded strong protection by reducing
not only cortical lesion but also WM deficits, indicating that
preventing primary neuronal death by autophagy inhibition
could reduce WM damage (Descloux et al., 2018).
Lesions mimicking human PVL were also observed in a
sheep model of severe hypoxia–ischemia (Table 4) involving a
double hit protocol and producing WM necrotic foci related
to GM (CX and TH) damage (transient maternal hypoxia and
Frontiers in Cell and Developmental Biology | www.frontiersin.org 13 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 14
Truttmann et al. Cell Death in Preterm Brain Injury
TABLE 6 | Cell death in preclinical models of excitotoxin-induced preterm brain injury.
Species Time of the insult Model Cell death markers
(time post insult)
+ Cell types ROIs Neuroprotectant References
Rat P5 SCWM ibotenate
injection (10 µg)
-c-CASP3, enhanced
autophagy (1 d)
-c-CASP3, Fluoro-Jade
B, AIF (1 d),
-cysts
-c-CASP3, TUNEL (1 d)
-NeuN
-n.d.
-n.d.
-n.d.
-CTX
-CTX
-PVWM
-CTX
-3-MA
-HIP/HAP; S18986,
-BDNF
-BDNF
Descloux et al., 2018
Destot-Wong et al., 2009;
Haldipur et al., 2014
Husson et al., 2005
Mouse P5 SCWM ibotenate
injection (10 µg)
-c-CASP3, AIF (5 d)
-c-CASP3, AIF,
Fluoro-Jade B (1 d)
-c-CASP3 (1 d, 2 d),
cysts
-c-CASP3 (1 d–30 d)
-TUNEL
-c-CASP3, TUNEL,
Fluoro-Jade B (1 d)
-TUNEL (1 d)
-n.d.
-n.d.
-n.d.
-n.d.
-GFAP
-n.d.
-n.d.
-CTX, SCWM
-CTX
-CTX
-CTX
-SCWM
-CTX
-CTX
-
-FBP
-CASP2 KO
-Substance P
-
-NAP
-melatonin
Griesmaier et al., 2010;
Neubauer et al., 2016
Dommergues et al., 2003;
Rogido et al., 2003;
Wegleiter et al., 2014
Carlsson et al., 2011
Medja et al., 2006
Tahraoui et al., 2001
Sokolowska et al., 2011
Husson et al., 2002
AIF = apoptosis-inducing factor; c-CASP3 = cleaved caspase-3; CTX = cortex; d = day; FBP = fructose 1,6-biphosphate; h = hours; HIP/PAP = hepatocarcinoma intestine
pancreas protein/pancreatitis-associated protein I; NAP = actif motif of ADNP (activity-dependent neuroprotective protein); 3MA = 3-methyladenine; P = postnatal day;
PVWM = periventricular WM; ROIs = regions of interest (i.e., where cell death is detected); SCWM = subcortical white matter.
TABLE 7 | Cell death in preclinical models of preterm brain injury following intracerebral hemorrhage.
Species Time of
the insult
Model Cell death
markers (time
post insult)
+ Cell types ROIs Neuroprotectant References
Mouse P1 i.c. autologous
blood (15 µl)
-TUNEL (2 d) -n.d. -ST, germinal matrix - Xue et al., 2003
P5 i.c.v. autologous
blood (20 µl)
-TUNEL (P23) -n.d. -PV SCWM -UC-MSCs Mukai et al., 2017
Rat P4 dam’s blood (100
µl) i.c.v.
-TUNEL (P32) -n.d. -PVZ -Human UC-MSCs Ahn et al., 2013
Rabbit 29 d ga,
(2 h, 3 h, or
4 h after
preterm
delivery
Glycerol (6.5 g/kg),
i.p
-TUNEL
-TUNEL
-c-CASP3 (1 d)
-TUNEL, Fluoro-Jade
B, CASP 3/7
activity (3 d)
-TUNEL, Fluoro-Jade
B (1-3 d)
-O4
-O4
-n.d.
-n.d.
-n.d.
-CR, CC
-CR, CC
-Choroid plexus
-PVA, CTX
-PVA, CTX
-NBQX
-NOG
–
-Celecoxib,
SC-51089,
etanercept
-Apocynin
Dohare et al., 2016
Dummula et al., 2011
Gram et al., 2014
Vinukonda et al., 2010
Georgiadis et al., 2008;
Zia et al., 2009
BG = basal ganglia; CC = corpus callosum; CASP3 = cleaved caspase-3; CG = cingulum; CTX = cortex; CR = corona radiate; d = day; ga = gestational age; h = hours;
i.c. = intracerebral; i.c.v. = intracerebroventricular; NOG = Noggin; P = postnatal day; PI = propidium iodide; PV = periventricular; PVA = periventricular area including
germinal matrix, caudate nucleus, corona radiata, and corpus callosum; ROIs = regions of interest (i.e., where cell death is detected); SCWM = subcortical white matter;
ST = striatum; UC-MSCs = umbilical cord-derived mesenchymal stromal cells.
brachiocephalic artery occlusion followed by a second hypoxia
6 h later) (Hagen et al., 2014).
Preclinical Models of Diffuse White
Matter Injury
While hypoxia/ischemia represents one of the major risk
factors for neonatal encephalopathy in term babies, for
preterm, however, inflammation has been of, in the last
decade, growing importance in the field. The role of a
hypoxic event in preterm brain injury has, indeed, no clear
evidence. Argument that is more rigorous is needed today
before claiming hypoxic–ischemic encephalopathy such as
measurement of hypoxemia and metabolic acidosis (Graham
et al., 2004; Gilles et al., 2017; Paneth, 2018). It is now
proposed that inflammation could be a leading cause of
preterm brain damage (Gilles et al., 2017). In human preterm
babies, chorioamnionitis and especially postnatal sepsis are
associated with WM injury and adverse neurodevelopmental
outcomes (Shah et al., 2008; Anblagan et al., 2016; Bierstone
et al., 2018; Heo et al., 2018). Moreover, inflammation
is a common process in different preterm brain injuries
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TABLE 8 | Cell death in preclinical models of iatrogenic preterm brain injury: hyperoxia.
Species Time of the
insult
Model Cell death markers
(time post insult)
+ Cell types ROIs Neuroprotectant References
Rat E21 80% O2 (8 d) -TUNEL (P3) -n.d. -WM -iNO Pham et al., 2014
E21 60% O2 (8 d) -TUNEL (P3) -n.d. -WM - Vottier et al., 2011
P0 80% O2 (5 d) -TUNEL, cell count (5 d) -Neurons
-Neurons
-CA1, CA3
-CA1, DG, prefrontal/
parietal/
retrosplenial CTX,
subiculum
-Uridine
-EPO
-Topiramate
Goren et al., 2017
Yis et al., 2008a
Yis et al., 2008b
Kurul et al., 2009
P2 95% O2 (5 d) -ELISA DNA fragm. -n.d. -CB, basal FB, frontal
CTX, Hipp
-BSO Taglialatela et al.,
1998
80% O2
-(1 d)
-TUNEL, AIF (5 d)
-c-CASP3 (1 d)
-TUNEL
-c-CASP3
-CASP2, 3, 8;
silver staining
-TUNEL (P7)
-CC1
-n.d.
-n.d.
-MBP
-n.d.
-Olig2
-CC, CG, eC
-CTX, WM
-frontal/
retrosplenial CTX,
HTH, TH
-CC
-CTX, STcn, NAcc,
CC and adjacent
WM, TH, Hipp,
HTH
- CC, deep cortical
WM, CTX, TH
-Minocycline
-Dextromethorphan
-Dexmedetomidine
-17β-estradiol
-EPO
-EPO
Schmitz et al., 2014
Posod et al., 2014
Sifringer et al.,
2015
Gerstner et al.,
2006
Gerstner et al.,
2007
Kaindl et al., 2008
Hoeber et al., 2016
P6 -(1 d or 2 d) -TUNEL, neuronal
density
-PARP-1, AIF,
c-CASP3
-Nestin, DCX,
NeuN
-n.d.
-Frontal/
retrosplenial
/parietal CTX, TH,
HTH
-Whole brain
-Caffeine
-Caffeine
Endesfelder et al.,
2014
Endesfelder et al.,
2017b
-(12 h or 1 d) -CASP2, Cyc, APAF-1,
AIF, BCL2, BID,
c-CASP3, Fluoro-Jade
B
-BECN1, ATG3, ATG5,
ATG12, LC3
-Neurons and n.d.
-n.d.
-TH
-Whole brain
-Caspase inhibitor
(TRP601)
-EPO
Sifringer et al.,
2012
Bendix et al., 2012
-(2 h, 6 h, 12 h, 1 d,
2 d, and 3 d)
-c-CASP8, c-CASP3,
Fas, FasL, FADD
-Fluoro-Jade B, silver
staining, CASP1
-n.d.
-n.d.
-CG, parietal CTX,
CC, ST, TH
-CASP8 inhibitor
(TRP801)
-Recombinant
IL-18BP
Dzietko et al., 2008
Felderhoff-Mueser
et al., 2005
Mouse P6 80% O2
-(2 h, 6 h, 12 h, 1 d,
2 d)
-(1 d)
-Fluoro-Jade B, silver
staining
-CASP2, CASP3,
CASP8, silver staining
-n.d.
-n.d.
-CG, parietal CTX,
CC, ST, TH
-CTX, STcn, NAcc,
CC and adjacent
WM, TH, Hipp,
HTH
-KO IRAK-4
-EPO
Felderhoff-Mueser
et al., 2005
Kaindl et al., 2008
P6 FasL + 80% O2 (1
d)
-c-CASP8, c-CASP3 -n.d. -Cingulate/parietal
CTX, CC, ST, TH
-CASP8 inhibitor
(TRP801)
Dzietko et al., 2008
AIF = apoptosis-inducing factor; BSO = buthionine sulfoxide; CC = corpus callosum; c-CASP = cleaved caspase; CG = cingulum; CTX = cortex; Cyc = cytochrome c;
d = day; DG = dentate gyrus; E = embryonic day; eC = external capsule; EPO = erythropoietin; FB = forebrain; h = hours; Hipp = hippocampus; HTH = hypothalamus;
iNO = inhaled nitric oxide; KO IRAK-4 = mice deficient in IL-1 receptor–associated kinase 4 (IRAK-4); NAcc = nucleus accumbens; n.d. = not defined; P = postnatal day;
recombinant IL-18BP = Recombinant interleukin–18 binding protein; ROIs = regions of interest (i.e., where cell death is detected); SCWM = subcortical white matter;
ST = striatum; STcn = striatal caudate nucleus; TH = thalamus; WM = white matter.
either directly as in intrauterine infection/chorioamnionitis or
secondarily because of a primary insult such as hemorrhage
or hypoxia/ischemia. Despite the current questioning of the
role of hypoxia in preterm brain damage, most of the
studies investigating cell death mechanisms in diffuse WM
injury have been performed in models involving both stimuli:
inflammation (Table 3) and hypoxia/ischemia (HI) (Tables 4, 5)
(Jantzie and Robinson, 2015).
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TABLE 9 | Cell death in preclinical models of iatrogenic preterm brain injury: caffeine and anesthetics.
Species Time of the insult Model Cell death
markers (time
post insult)
+ Cell types ROIs Neuroprotectant References
Rat E20 Propofol,
maternal i.v.
(8.0 mg/kg) +
1 h
(1.2 mg/kg/min)
-c-CASP3 (6 h) -NeuN -CTX, TH, HTH Dexmedetomidine Li et al., 2016a
E14 Sevoflurane,
maternal (3.5%)
for 2 h
-↑LC3-II,
↑BECLIN-1,
↓SQSTM1,
↓mTOR,
TUNEL,
↓BCL2, (2 h,
12 h, 1 d, 2 d)
-Nestin+ Whole brain 3-MA Li X. et al.,
2017
P3 Caffeine,
1 × i.p.
(80 mg/kg)
c-CASP3 (6 h) n.d. Whole brain
(Hipp, ST, TH,
CTX)
– Cabrera et al.,
2017
P4 Caffeine,
1 × /d i.p., for
3 d (10 mg/kg)
TUNEL (6 h,
12 h, 1 d)
n.d. HTH, DG – Endesfelder
et al., 2017a
P6 Caffeine,
1 × (10 mg/kg)
PARP-1, AIF (1
d or 2 d)
n.d. Whole brain – Endesfelder
et al., 2017b
P3 MgSO4,
1 × /h, for 3 h
(4× 250 mg/kg)
c-CASP3,
apoptotic by
EM
Neurons CTX, STcn,
STp, Hipp, TH,
CB c
– Dribben et al.,
2009
E20 Propofol,
maternal i.v.
(8.0 mg/kg) +
1 h
(1.2 mg/kg/min)
-c-CASP3 (6 h) -NeuN -CTX, TH, HTH Dexmedetomidine Li et al., 2016a
P4 Phenobarbital,
1 × /d i.p., for
3 d
(50 mg/kg)
-TUNEL (6 h,
12 h, 1 d)
-n.d. Frontal CTX,
retrosplenial
CTX, HTH, TH,
DG
– Endesfelder
et al., 2017a
Mouse E14 Sevoflurane
(2.5%), 2 h
-c-CASP3 -n.d. Whole brain – (Zheng et al.,
2013)
P6 Sevoflurane
(3%) or
isoflurane
(2%) or
desflurane
(4/8%), for
2 h/3 h or 6 h
-c-CASP3,
c-PARP,
TUNEL (18 h)
-c-CASP3,
TUNEL (2 d)
-n.d -CX, Hipp, Am,
TH, ST, CP
-Hipp
-Hipp
-
-Luteolin
-Tanshinone IIA
Kodama et al.,
2011
Wang Y. et al.,
2019
Xia et al., 2017
P6 Sevoflurane
(3%), 1 × /d for
2 h, for 3 d
↑LC3-II,
↓SQSTM1,
n.d Hipp 3-MA Wang X. et al.,
2019
P3 -Midazolam,
1 × i.p.
(6 mg/kg);
ketamine,
1 × i.p.
(40 mg/kg);
fentanyl,
1 × i.p. (40
µg/kg)
+ caffeine
(80 mg/kg)
c-CASP3 (6 h) n.d. Whole brain
(Hipp, ST, TH,
CTX)
– Cabrera et al.,
2017
P5–P7 Propofol, i.p.
(50/100 mg/kg)
c-CASP3 n.d. STcn, CTX – Cattano et al.,
2008
(Continued)
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TABLE 9 | Continued
Species Time of the insult Model Cell death
markers (time
post insult)
+ Cell types ROIs Neuro-
protectant
References
Rhesus
macaque
100–120 d ga Isoflurane
(5 h)
3 h before
preterm delivery
c-CASP3 MBP, NeuN - ST, PT – Noguchi et al.,
2018
120 d ga Propofol, i.v.
(5 h), 3 h before
preterm delivery
c-CASP3
fractin (3 h)
MBP, neurons CTX, STcn,
STp, Am, CB,
infCOLL
CSO, CC, iC
– Creeley et al.,
2013
120 d ga100–120 d ga -Isoflurane, i.v.
(0.7–1.5 vol%),
5 h, 3 h before
preterm delivery
- + caffeine
(1 × 80 mg/kg,
1 × /d
20 mg/kg)
-c-CASP3 (3 h)
-↑ c-CASP3
-MBP, NeuN
-MBP, NeuN
CTX, STcn,
STp, Am, CB,
-CB, ST
–
–
Creeley et al.,
2014
Noguchi et al.,
2018
120 d ga Ketamine, i.v.
(10 mg/kg) +
5 h (10–
85 mg/kg/min)
c-CASP3 (3 h) n.d. CTX, STcn,
STp, Am, GP,
CB
– Brambrink
et al., 2012
AIF = apoptosis-inducing factor; Am = amygdala, CB = cerebellum; CC = corpus callosum; c-CASP = cleaved caspase; CSO = centrum semiovale, CG = cingulum;
CTX = cortex; Cyc = cytochrome c; d = day; DG = dentate gyrus; E = embryonic day; eC = external capsule; EM = electronic microscopy; EPO = erythropoietin;
FB = forebrain; GP = globus pallidus; h = hours; Hipp = hippocampus; HTH = hypothalamus; iC = internal capsule, infCOLL = inferior colliculus NAcc = nucleus
accumbens; n.d. = not defined; P = postnatal day; ROIs = regions of interest (i.e., where cell death is detected); SCWM = subcortical white matter; ST = striatum;
STcn = striatal caudate nucleus; STp = striatal putamen; TH = thalamus; WM = white matter.
Preclinical Inflammatory Models
Direct inflammatory lesions are induced in most of the preclinical
models by an acute or chronic exposure to either gram-negative
bacteria lipopolysaccharide (LPS) endotoxin or more recently by
injection of interleukin-1β that leads to a persistent inflammatory
response, astrogliosis, and myelination deficits (Dean et al.,
2015). It has been shown that exposure to inflammation during
the perinatal period could alter transiently or permanently
neurodevelopmental outcome (learning and motor difficulties
and development of psychiatric disease such as schizophrenia
or autism) (Fan et al., 2005b; Boksa, 2010; Rousset et al., 2013;
Schaafsma et al., 2017; Straley et al., 2017; Zhang et al., 2018).
Cell death has been mostly investigated in models of fetal
infection in rat, sheep, and macaques in which apoptotic cell
death (c-CASP3) was found to be scattered, located essentially
in WM, and observed mainly after days following inflammatory
insult (Table 3). When investigated, cell type identification
indicated that CASP3 activation occurred in oligodendrocyte
lineage (Olig2, CNPase, and PDGFαR). However, injury of the
GM was also described. A study in sheep involving intra-amniotic
LPS injection also described CASP3 activation in the cortex and
the hippocampus 8 days after LPS exposure (Gussenhoven et al.,
2018). Another study involving i.p. LPS injections in rat dam
(at E18 and E19) showed the presence of TUNEL and c-CASP3-
positive cells in the periventricular striatum of pups 7 days after
birth (Rousset et al., 2006).
An intracerebral injection of LPS consists of much more
severe inflammatory models by mimicking late conditions of
pathogen infiltration after the breakdown of the blood–brain
barrier. In a model of LPS exposure in postnatal rat (P3),
the production of the CASP-dependent fragment of β-actin,
fractin, was observed in the subcortical WM (SCWM) as
well as in axonal fascicles of striatum (Lodygensky et al.,
2014; Ginet et al., 2016), suggesting a LPS-induced axonopathy
(Sokolowski et al., 2014). The mechanisms involved in apoptosis
induction could depend on the cell type. In fact, in a model
of intracerebral injection of IL-1β in P5 rats inducing a
global CASP3 activation, TUNEL staining was observed in
Lectin+microglia, in O4+ and O1+ oligodendrocyte precursors,
and in some NF+ neurons 1 day after the insult (Cai
et al., 2004). Inflammation-related cell death was partially
associated with excitotoxicity since the AMPA/kainate receptors
antagonist NBQX reduced the global number of TUNEL+
cells without protecting oligodendrocyte precursors. This could
be explained by an age-dependent sensitivity of WM pre-
oligodendrocytes to AMPA toxicity that occurs later at P7
(Follett et al., 2000).
A single study investigated autophagy in an inflammatory
model (Carloni et al., 2016), showing that, when LPS was injected
in the rat dam (at E18 and E19), autophagy appeared impaired
(LC3-II and p62/SQSTM1 levels were increased in P1 brain
rat pups). However, this study evaluated the overall autophagy
response on whole brain extracts, a method that limits the
conclusions concerning the effect on autophagy according to
either WM, GM, or the cell type.
Very recently, an involvement of necroptosis has been
proposed to occur after LPS-induced brain inflammation in
P3 old rats by showing an increase in necroptotic gene
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expressions (RIPK1, RIPK3, and MLKL) 24 h after the insult
(Pierre et al., 2019).
Hypoxic–Ischemic Models
Even if the role of HI has become a subject of debate (Gilles
et al., 2017), it remains one of the most used models for studying
preterm brain injury that induces both severe WM and GM injury
and are then used mainly as a model of cPVL. Cell death has been
investigated mainly in sheep and rodent (Table 4).
Sheep models consist in inducing a hypoxic–ischemic event in
the fetus by either umbilical cord occlusion or by brachiocephalic
arteries occlusion combined with maternal hypoxia. CASP3
activation, pyknotic nuclei, as well as TUNEL staining were
described mainly in PVWM (periventricular and subcortical
WM) and SCWM but also in cortex, basal ganglia (caudate
nucleus and putamen), and less frequently in thalamus,
hypothalamus, and hippocampus. One study investigating cell
death within the first 3 h following HI showed that necrotic
features are detected early, from time zero onwards, without
signs of apoptosis in different cerebral regions (mesencephalon,
cerebellum, pons, basal ganglia, cortex, hippocampus, thalamus,
and hypothalamus) (Goni-de-Cerio et al., 2007). From 3 h
onwards, apoptotic dying cells are detected and not restricted
to cerebral regions where necrotic neurons were histologically
observed at 0 h (mesencephalon, cerebellum, pons, and basal
ganglia). Interestingly, some early necrotic regions will then
become strongly apoptotic later (especially cortex, cerebellum,
and pons), suggesting that different cell death processes are
involved sequentially in the same damaged cerebral region.
However, since all these observations are focused on unregulated
necrosis, it could be speculated that regions displaying either
apoptotic or necrotic features at later time points are regions
where delayed cell death is prominent, including potentially
not only apoptosis but also a regulated form of necrosis
such as necroptosis.
The subplate zone is a transient layer of the developing
cerebral cortex that plays a highly important role in the structural
brain development and its plasticity. It contains different
neuronal cells and especially early-generated subplate neurons
whose cell bodies are located in developing WM. Subplate
injury has been since years discussed in EoP and is becoming
more and more important over the last decade. When sheep
maternal hypoxia and fetal ischemia were induced early (92d
GA), CASP3 activation was also present in the subplate but
essentially in oligodendrocytes, suggesting a more important
resistance of subplate neurons in sheep (McClendon et al., 2017).
On the contrary, selective vulnerability of subplate neurons
was described in the most widely used model of HI in P2–P3
rodents (uniCCAO followed by systemic hypoxia) (McQuillen
et al., 2003; Mikhailova et al., 2017). However, another study
could not confirm a specific vulnerability of subplate neurons
compared to other deep layers or to the WM (Okusa et al.,
2014). It is important to point out that these studies have
evaluated only the density of neurons in the subplate and did
not perform co-labeling with cell death markers, which is not
sufficient to conclude for a specific neuron death in the subplate
since an impairment in neuronal differentiation could also be
involved. In a different rat model consisting in placental transient
hypoxia–ischemia at E18 (uterine arteries occlusion), however,
the presence of TUNEL+ neurons has been reported in the
subplate at P2 (Jantzie et al., 2015a).
Even if widespread CASP3 activation or TUNEL labeling
were shown in models of HI in P1 to P6 rodents in both GM
(cortex, thalamus) and WM (Segovia et al., 2008; Jablonska
et al., 2012; Scafidi et al., 2014; Seyama et al., 2018), few studies
characterized the type of dying cells. In a mouse model of
chronic hypoxia (8 days at 10.5% O2 from P3), oligodendrocytes
were shown to undergo CASP3-dependent apoptosis even 1
week after the end of hypoxic treatment (Jablonska et al.,
2012). In the model of HI in P3 rats pups, Segovia and
colleagues (Segovia et al., 2008) showed that, in addition to pre-
oligodendrocyte maturation arrest, O4+ cells underwent mainly
caspase-independent cell death mechanisms (c-CASP3 negative
but morphological characteristics of degeneration) 24 h after the
insult, whereas 4 days later, they died mostly through caspase-
dependent pathways, suggesting that different forms of cell death
are involved in acute or delayed cell death of oligodendrocytes
(Segovia et al., 2008).
In a model of anoxia in P1 rat pups, damaged hippocampus
showed cell death with EM mixed morphological features of
apoptosis, necrosis, and enhanced autophagy (Takada et al.,
2015), suggesting that more than one cell death type could be
involved in hypoxic–ischemic brain damage with a continuum
of cell death that could include the three cell death types as it has
been proposed in models of HI in more mature P7 brain (Portera-
Cailliau et al., 1997; Ginet et al., 2009a; Northington et al.,
2011). Interestingly, this study showed that whereas CA2/CA3
presented a neurodegeneration revealed by both Fluoro-Jade B+
staining and EM ultrastructure study, this hippocampal region
was TUNEL negative and presented no more CASP3 activation
than in control. This result points out the necessity to study
cell death with alternative markers of cell death, different from
CASP3 activation (that is moreover developmentally expressed
in the immature brain) and TUNEL staining.
In summary, in inflammatory and/or HI premature models,
cell death has been investigated in different models and species,
and is present in cortical and deep GM neurons and in different
glial cells (OL and microglia) with different cell death features
reported (necrosis, apoptosis, and autophagic cell death).
Preclinical Models of Intraventricular and
Intraparenchymatous Hemorrhages
Very few studies have investigated cell death occurring after
IVH in preclinical preterm models (Table 7). Cell death has
been studied in two main models reproducing the conditions of
germinal matrix hemorrhage (GMH) (germinal matrix ruptures
through the ependyma into the lateral ventricle) leading to IVH
in preterm human brains. The first approach consists of applying
periventricular or intracerebroventricular injections of blood
(from dam or autologous) in rodent pups (P1 to P4). The second
approach is to perform an i.p. injection of glycerol in rabbit fetus
(29 days GA) that produces an intracranial pressure through
profound osmotic changes followed by a reperfusion leading to
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GMH that can extend to the lateral ventricle (Table 7). In both
models, pups developed severe IVH associated with progressive
post-hemorrhagic hydrocephalus (PHH) compatible with grade
3 or grade 4 IVH in humans, even if the percentage of induced
PHH is variable. The IVH pups displayed impaired sensorimotor
functions, inflammation, defects in myelination, and increased
levels of inflammatory cytokines in the CSF.
Increased cell death and apoptosis have been evidenced by
TUNEL staining and CASP3 activation in the periventricular
WM (Dummula et al., 2011; Ahn et al., 2013; Gram et al., 2014;
Dohare et al., 2016; Mukai et al., 2017) and adjacent GM [striatum
(Xue et al., 2003) or cortex (Georgiadis et al., 2008; Zia et al.,
2009; Vinukonda et al., 2010)]. However, the identification of
the dying cells has not been determined except in some studies
showing that cell death (Fluoro-Jade+ cells) could affect O4+
pre-oligodendrocytes or neurons.
Preclinical Models of Iatrogenic Preterm
Brain Injury
Hyperoxia
The involvement of cell death and apoptosis in preterm brain
injury is well documented in preterm models of hyperoxia in
postnatal rodent (from P0 to P6) (Table 8). Hyperoxia was
shown in those models to affect both WM and GM (cortex,
striatum, thalamus, and hippocampus) by promoting cell death of
oligodendrocytes (Gerstner et al., 2006, 2007; Schmitz et al., 2014;
Hoeber et al., 2016) and neurons (Yis et al., 2008a,b; Endesfelder
et al., 2014). The involvement of apoptosis as a major cell death
process was demonstrated by the implication of not only CASP3
but also numerous molecular markers of both intrinsic (Cyc, AIF,
and APAF-1) and extrinsic (Fas, FasL, FADD, CASP8, and BID)
apoptotic pathways inducing caspase-dependent (CASP1, 2, 3,
and 8) and independent (AIF) mechanisms.
Furthermore, Bendix and colleagues (Bendix et al., 2012)
showed an effect of hyperoxia on autophagy during the first 24 h
of hyperoxia in the developing rat preterm brain. Some important
autophagy-related genes (atg) for autophagosome formation
were upregulated (BECLIN1, ATG3, ATG5, ATG12, and LC3-II)
(Bendix et al., 2012) at 12 h after hyperoxia treatment. However,
we cannot conclude on the effect of hyperoxia on autophagic
flux (active autophagic process of degradation) since efficiency of
the degradative part of autophagy was not investigated. Increased
autophagosome presence could result from enhanced autophagic
flux as well as impaired lysosomal degradation (Puyal et al., 2013;
Klionsky et al., 2016). While this study showed that autophagy is
certainly affected by hyperoxia, more investigations (assessing the
state of the flux and its function) are needed before to conclude
on the role of autophagy in hyperoxia-mediated cell death.
Caffeine
It has been shown that caffeine treatment (10 to 80 mg/kg,
i.p.) activated apoptosis (CASP3, AIF) and increased TUNEL
staining in the brain of rat pups (P3, P6) (Table 9) (Cabrera
et al., 2017; Endesfelder et al., 2017a,b). Recently, Noguchi and
colleagues showed that caffeine treatment in fetal macaque (110–
120 days GA) anesthetized with isoflurane strongly sensitized
brain (CX, ST, and CB) against isoflurane-induced apoptosis,
especially NeuN-positive neurons, more than MBP-positive
oligodendrocytes (Noguchi et al., 2018).
Anesthetics
Different studies demonstrated pro-apoptotic effects of
anesthetics [especially propofol, ketamine, and ethers (isoflurane,
sevoflurane)] on immature brain of rodents and macaques
(Table 9). Combination of anesthetic with caffeine is a powerful
aggravating factor (Noguchi et al., 2018). These anesthetics
have been shown to trigger widespread CASP3 activation or
to increase TUNEL labeling in neurons and oligodendrocytes
(Cattano et al., 2008; Dribben et al., 2009; Brambrink et al., 2010,
2012; Creeley et al., 2013; Li et al., 2016a; Xiong et al., 2016)
associated with some cognitive deficits. In two studies using
sevoflurane, autophagy was shown to be enhanced, in addition to
apoptosis, in immature brains, and autophagy inhibition using
3-MA was both anti-apoptotic and neuroprotective (Li X. et al.,
2017; Wang X. et al., 2019).
CONCLUSION AND FUTURE
PROSPECTS
In conclusion, common and converging observations from
animal models and human brains from autopsy suggested that
cell death mechanisms in preterm brain injuries mainly involve
apoptotic mechanisms. Although most of the studies missed to
identify the type of cells subjected to cell death, some suggested
that different cell types are affected depending not only on the
severity and the type of the insult but also on the time point
investigated. In mild preterm injuries, the cell death appeared
to be diffuse and restricted (when detected) to preOL, whereas
in more severe cases, cell death could affect almost all cell types
including neurons.
Nevertheless, it appears that, although cell death is an
ineluctable event occurring in severe preterm brain injuries
such as cPVL and IVH, but not necessarily in dWMI, cell
death has not been deeply investigated and characterized
either in preclinical models or in tissues from human preterm
neonates. The importance of apoptosis versus other cell death
pathways (such as regulated necrotic and autophagic) is certainly
overestimated since almost all the studies used only apoptotic
(such as c-CASP3 and TUNEL) markers as indicators of
cell death. Moreover, by using only c-CASP3 and TUNEL
markers, cell death occurrence can be simply underestimated
or wrongly declared absent since cell death types independent
of CASP3 and not inducing (at least in an early stage)
DNA fragmentation exist. In the model of anoxia in P1 rat
pups, damaged hippocampal CA2/CA3 showed, for example,
cell death mechanisms mainly independent of CASP3, not
positive for TUNEL and with EM morphological features of
necrosis and enhanced autophagy (Takada et al., 2015). We
have previously clearly demonstrated the presence and the
prodeath role of enhanced neuronal autophagy in models of
both term (Ginet et al., 2009b; Puyal et al., 2009; Ginet
et al., 2014a; Xie et al., 2016) and more recently preterm
(Descloux et al., 2018) brain injury. We showed that, after
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neonatal cerebral HI, rat hippocampal dying CA3 neurons
displayed high autophagic features without apoptosis activation,
i.e., TUNEL and CASP3 negative (Ginet et al., 2009b). In
addition, the discovery of programmed forms of necrosis and
some of its molecular actors will allow one to investigate
the implication of regulated necrosis. Necroptosis is especially
concerned since this type of cell death is known to be activated
by inflammatory signals.
Since “we find what we are looking for”, one could speculate
that most of the studies missed to identify cell death mechanisms
involved in the pathogenesis of the studied preterm brain
damage. The increasing advances made to understand the
biochemical mechanisms of the different cell death pathways
and the recognition of regulated necrosis and autophagic
cell death lead to switch, over the last 10 years, in the
identification of the cell death type from a purely morphological
to a molecular analysis (Galluzzi et al., 2012). Today, many
markers of the different types of cell death could be used
in human samples to systematically evaluate the presence
not only of apoptosis but also of other forms of cell death
including regulated necrosis and autophagic or autophagy-
mediated cell death. Expression and activation of RIPK3
and MLKL could be investigated as markers for necroptosis.
Concerning autophagic or autophagy-mediated cell death, an
increase in autophagosome presence alone is not enough to
demonstrate an increased autophagic flux since it could result
from a lysosomal degradation failure. Then, an increase in
punctate LC3 immunolabeling (marker of autophagosomes)
together with an increase lysosomal activity, evaluated by either
a decrease in p62/SQSTM1 labeling (selectively degraded by
autophagy) or an increase in the size and number of vesicles
labeled by lysosomal markers such as LAMP1 or different
cathepsins (presumably autolysosomes), should be used to
detect enhanced autophagy. Moreover, since increased autophagy
could be either a prosurvival or a prodeath mechanism,
conclusions on the role of enhanced autophagy in cell death
has to be taken with caution due to the duality of autophagy
in cell survival (protective vs. destructive) depending the
conditions and cell type.
Future studies designed to provide a more precise
characterization of the molecular cell death mechanisms and also
identification of dying cell types will allow a better understanding
of the preterm brain pathogenesis and will certainly participate
to develop new and efficient protective strategies to prevent or
treat injuries of the preterm human brain.
AUTHOR CONTRIBUTIONS
AT, VG, and JP conceived, wrote the manuscript, drew the tables
and figures, and critically revised the manuscript.
FUNDING
This work was supported by the grants from the Swiss National
Science Foundation (310030-163064 and 310030-182332) and by
the Fondation Paralysie Cérébrale.
REFERENCES
Abedin, N., Ashraf, Q., Mishra, O. P., and Delivoria-Papadopoulos, M. (2005).
Effect of hypoxia on the expression of pro- and anti-apoptotic proteins in
neuronal nuclei of the guinea pig fetus during gestation. Brain Res. Dev. Brain
Res. 156, 32–37. doi: 10.1016/j.devbrainres.2005.01.006
Ahn, S. Y., Chang, Y. S., Sung, D. K., Sung, S. I., Yoo, H. S., Lee, J. H., et al. (2013).
Mesenchymal stem cells prevent hydrocephalus after severe intraventricular
hemorrhage. Stroke 44, 497–504. doi: 10.1161/STROKEAHA.112.679092
Alonso-Alconada, D., Alvarez, F. J., Alvarez, A., Mielgo, V. E., Goni-de-Cerio,
F., Rey-Santano, M. C., et al. (2010). The cannabinoid receptor agonist WIN
55,212-2 reduces the initial cerebral damage after hypoxic-ischemic injury in
fetal lambs. Brain Res. 1362, 150–159. doi: 10.1016/j.brainres.2010.09.050
Anblagan, D., Pataky, R., Evans, M. J., Telford, E. J., Serag, A., Sparrow, S.,
et al. (2016). Association between preterm brain injury and exposure to
chorioamnionitis during fetal life. Sci. Rep. 6:37932. doi: 10.1038/srep37932
Andiman, S. E., Haynes, R. L., Trachtenberg, F. L., Billiards, S. S., Folkerth,
R. D., Volpe, J. J., et al. (2010). The cerebral cortex overlying periventricular
leukomalacia: analysis of pyramidal neurons. Brain Pathol. 20, 803–814. doi:
10.1111/j.1750-3639.2010.00380.x
Askie, L. M., Brocklehurst, P., Darlow, B. A., Finer, N., Schmidt, B., Tarnow-Mordi,
W., et al. (2011). NeOProM: neonatal oxygenation prospective meta-analysis
collaboration study protocol. BMC Pediatr. 11:6. doi: 10.1186/1471-2431-11-6
Baburamani, A. A., Supramaniam, V. G., Hagberg, H., and Mallard, C. (2014).
Microglia toxicity in preterm brain injury. Reprod. Toxicol. 48, 106–112. doi:
10.1016/j.reprotox.2014.04.002
Back, S. A., Luo, N. L., Mallinson, R. A., O’Malley, J. P., Wallen, L. D., Frei,
B., et al. (2005). Selective vulnerability of preterm white matter to oxidative
damage defined by F2-isoprostanes. Ann. Neurol. 58, 108–120. doi: 10.1002/ana.
20530
Back, S. A., Riddle, A., Dean, J., and Hohimer, A. R. (2012). The instrumented
fetal sheep as a model of cerebral white matter injury in the premature infant.
Neurotherapeutics 9, 359–370. doi: 10.1007/s13311-012-0108-y
Back, S. A., and Volpe, J. J. (2018). “Encephalopathy of prematurity:
pathophysiology. pathophysiology,” in Volpe’s Neurology of the Newborn,
(Amsterdam: Elsevier), 405.e8–424.e8.
Balakrishnan, B., Dai, H., Janisse, J., Romero, R., and Kannan, S. (2013). Maternal
endotoxin exposure results in abnormal neuronal architecture in the newborn
rabbit. Dev. Neurosci. 35, 396–405. doi: 10.1159/000353156
Ball, G., Boardman, J. P., Aljabar, P., Pandit, A., Arichi, T., Merchant, N., et al.
(2013). The influence of preterm birth on the developing thalamocortical
connectome. Cortex 49, 1711–1721. doi: 10.1016/j.cortex.2012.07.006
Banker, B. Q., and Larroche, J. C. (1962). Periventricular leukomalacia of infancy.
A form of neonatal anoxic encephalopathy. Arch. Neurol. 7, 386–410.
Baud, O., and Saint-Faust, M. (2019). Neuroinflammation in the developing
brain: risk factors. involvement of microglial cells, and implication for early
anesthesia. Anesth. Analg. 128, 718–725. doi: 10.1213/ANE.0000000000004032
Beauport, L., Schneider, J., Faouzi, M., Hagmann, P., Huppi, P. S., Tolsa, J. F.,
et al. (2017). Impact of early nutritional intake on preterm brain: a magnetic
resonance imaging study. J. Pediatr. 181:e21. doi: 10.1016/j.jpeds.2016.09.073
Bendix, I., Schulze, C., Haefen, C., Gellhaus, A., Endesfelder, S., Heumann, R., et al.
(2012). Erythropoietin modulates autophagy signaling in the developing rat
brain in an in vivo model of oxygen-toxicity. Int. J. Mol. Sci. 13, 12939–12951.
doi: 10.3390/ijms131012939
Bennet, L., Roelfsema, V., George, S., Dean, J. M., Emerald, B. S., and Gunn, A. J.
(2007). The effect of cerebral hypothermia on white and grey matter injury
induced by severe hypoxia in preterm fetal sheep. J. Physiol. 578(Pt 2), 491–506.
doi: 10.1113/jphysiol.2006.119602
Bierstone, D., Wagenaar, N., Gano, D. L., Guo, T., Georgio, G., Groenendaal, F.,
et al. (2018). Association of histologic chorioamnionitis with perinatal brain
Frontiers in Cell and Developmental Biology | www.frontiersin.org 20 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 21
Truttmann et al. Cell Death in Preterm Brain Injury
injury and early childhood neurodevelopmental outcomes among preterm
neonates. JAMA Pediatr. 172, 534–541. doi: 10.1001/jamapediatrics.2018.0102
Billiards, S. S., Haynes, R. L., Folkerth, R. D., Borenstein, N. S., Trachtenberg, F. L.,
Rowitch, D. H., et al. (2008). Myelin abnormalities without oligodendrocyte loss
in periventricular leukomalacia. Brain Pathol. 18, 153–163. doi: 10.1111/j.1750-
3639.2007.00107.x
Boksa, P. (2010). Effects of prenatal infection on brain development and behavior:
a review of findings from animal models. Brain Behav. Immun. 24, 881–897.
doi: 10.1016/j.bbi.2010.03.005
Brambrink, A. M., Evers, A. S., Avidan, M. S., Farber, N. B., Smith, D. J.,
Martin, L. D., et al. (2012). Ketamine-induced neuroapoptosis in the fetal and
neonatal rhesus macaque brain. Anesthesiology 116, 372–384. doi: 10.1097/
ALN.0b013e318242b2cd
Brambrink, A. M., Evers, A. S., Avidan, M. S., Farber, N. B., Smith, D. J.,
Zhang, X., et al. (2010). Isoflurane-induced neuroapoptosis in the neonatal
rhesus macaque brain. Anesthesiology 112, 834–841. doi: 10.1097/ALN.
0b013e3181d049cd
Brew, N., Azhan, A., den Heijer, I., Boomgardt, M., Davies, G. I., Nitsos, I., et al.
(2016). Dopamine treatment during acute hypoxia is neuroprotective in the
developing sheep brain. Neuroscience 316, 82–93. doi: 10.1016/j.neuroscience.
2015.12.022
Broad, K. D., Kawano, G., Fierens, I., Rocha-Ferreira, E., Hristova, M., Ezzati,
M., et al. (2017). Surgery increases cell death and induces changes in gene
expression compared with anesthesia alone in the developing piglet brain. PLoS
One 12:e0173413. doi: 10.1371/journal.pone.0173413
Buser, J. R., Maire, J., Riddle, A., Gong, X., Nguyen, T., Nelson, K., et al. (2012).
Arrested preoligodendrocyte maturation contributes to myelination failure in
premature infants. Ann. Neurol. 71, 93–109. doi: 10.1002/ana.22627
Buser, J. R., Segovia, K. N., Dean, J. M., Nelson, K., Beardsley, D., Gong, X., et al.
(2010). Timing of appearance of late oligodendrocyte progenitors coincides
with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-
ischemia. J. Cereb. Blood Flow Metab. 30, 1053–1065. doi: 10.1038/jcbfm.2009.
286
Cabrera, O. H., O’Connor, S. D., Swiney, B. S., Salinas-Contreras, P., Manzella,
F. M., Taylor, G. T., et al. (2017). Caffeine combined with sedative/anesthetic
drugs triggers widespread neuroapoptosis in a mouse model of prematurity.
J. Matern. Fetal. Neonatal. Med. 30, 2734–2741. doi: 10.1080/14767058.2016.
1261400
Cai, Z., Lin, S., Pang, Y., and Rhodes, P. G. (2004). Brain injury induced by
intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in
the neonatal rat. Pediatr. Res. 56, 377–384. doi: 10.1203/01.PDR.0000134249.
92944.14
Carloni, S., Favrais, G., Saliba, E., Albertini, M. C., Chalon, S., Longini, M.,
et al. (2016). Melatonin modulates neonatal brain inflammation through
endoplasmic reticulum stress, autophagy, and miR-34a/silent information
regulator 1 pathway. J. Pineal. Res. 61, 370–380. doi: 10.1111/jpi.12354
Carlsson, Y., Schwendimann, L., Vontell, R., Rousset, C. I., Wang, X., Lebon, S.,
et al. (2011). Genetic inhibition of caspase-2 reduces hypoxic-ischemic and
excitotoxic neonatal brain injury. Ann. Neurol. 70, 781–789. doi: 10.1002/ana.
22431
Castillo-Melendez, M., Baburamani, A. A., Cabalag, C., Yawno, T., Witjaksono, A.,
Miller, S. L., et al. (2013). Experimental modelling of the consequences of brief
late gestation asphyxia on newborn lamb behaviour and brain structure. PLoS
One 8:e77377. doi: 10.1371/journal.pone.0077377
Cattano, D., Young, C., Straiko, M. M., and Olney, J. W. (2008). Subanesthetic
doses of propofol induce neuroapoptosis in the infant mouse brain. Anesth.
Analg. 106, 1712–1714. doi: 10.1213/ane.0b013e318172ba0a
Chamnanvanakij, S., Margraf, L. R., Burns, D., and Perlman, J. M. (2002).
Apoptosis and white matter injury in preterm infants. Pediatr. Dev. Pathol. 5,
184–189. doi: 10.1007/s10024-001-0205-0
Chau, V., Synnes, A., Grunau, R. E., Poskitt, K. J., Brant, R., and Miller, S. P.
(2013). Abnormal brain maturation in preterm neonates associated with
adverse developmental outcomes. Neurology 81, 2082–2089. doi: 10.1212/01.
wnl.0000437298.43688.b9
Clarke, P. G. (1990). Developmental cell death: morphological diversity and
multiple mechanisms. Anat. Embryol. 181, 195–213.
Clarke, P. G., and Puyal, J. (2012). Autophagic cell death exists. Autophagy 8,
867–869. doi: 10.4161/auto.20380
Creeley, C., Dikranian, K., Dissen, G., Martin, L., Olney, J., and Brambrink, A.
(2013). Propofol-induced apoptosis of neurones and oligodendrocytes in fetal
and neonatal rhesus macaque brain. Br. J. Anaesth. 110(Suppl. 1), i29–i38.
doi: 10.1093/bja/aet173
Creeley, C. E., Dikranian, K. T., Dissen, G. A., Back, S. A., Olney, J. W.,
and Brambrink, A. M. (2014). Isoflurane-induced apoptosis of neurons and
oligodendrocytes in the fetal rhesus macaque brain. Anesthesiology 120, 626–
638. doi: 10.1097/ALN.0000000000000037
Cuervo, A. M. (2004). Autophagy: many paths to the same end. Mol. Cell Biochem.
263, 55–72. doi: 10.1023/B:MCBI.0000041848.57020.57
de Vries, L. S., Groenendaal, F., Liem, K. D., Heep, A., Brouwer, A. J.,
van ’t Verlaat, E., et al. (2019). Treatment thresholds for intervention in
posthaemorrhagic ventricular dilation: a randomised controlled trial. Arch.
Dis. Child Fetal. Neonatal. Ed. 104, F70–F75. doi: 10.1136/archdischild-2017-31
4206
Dean, J. M., Farrag, D., Zahkouk, S. A., El Zawahry, E. Y., Hagberg, H., Kjellmer,
I., et al. (2009). Cerebellar white matter injury following systemic endotoxemia
in preterm fetal sheep. Neuroscience 160, 606–615. doi: 10.1016/j.neuroscience.
2009.02.071
Dean, J. M., Gunn, A. J., Wassink, G., George, S., and Bennet, L. (2006).
Endogenous alpha2-adrenergic receptor-mediated neuroprotection after severe
hypoxia in preterm fetal sheep. Neuroscience 142, 615–628. doi: 10.1016/j.
neuroscience.2006.06.066
Dean, J. M., Shi, Z., Fleiss, B., Gunn, K. C., Groenendaal, F., van Bel, F., et al.
(2015). ). A Critical Review of Models of Perinatal Infection. Dev. Neurosci. 37,
289–304. doi: 10.1159/000370309
Dean, J. M., Wang, X., Kaindl, A. M., Gressens, P., Fleiss, B., Hagberg, H., et al.
(2010). Microglial MyD88 signaling regulates acute neuronal toxicity of LPS-
stimulated microglia in vitro. Brain Behav. Immun. 24, 776–783. doi: 10.1016/j.
bbi.2009.10.018
Debillon, T., Gras-Leguen, C., Leroy, S., Caillon, J., Rozé, J. C., and Gressens,
P. (2003). Patterns of cerebral inflammatory response in a rabbit model of
intrauterine infection-mediated brain lesion. Dev. Brain Res. 145, 39–48. doi:
10.1016/s0165-3806(03)00193-7
Debillon, T., Gras-Leguen, C., Verielle, V., Winer, N., Caillon, J., Roze, J. C.,
et al. (2000). Intrauterine infection induces programmed cell death in rabbit
periventricular white matter. Pediatr. Res. 47, 736–742. doi: 10.1203/00006450-
200006000-00009
Debnath, J., Baehrecke, E. H., and Kroemer, G. (2005). Does autophagy contribute
to cell death? Autophagy 1, 66–74. doi: 10.4161/auto.1.2.1738
Del Bigio, M. R. (2011). Cell proliferation in human ganglionic eminence and
suppression after prematurity-associated haemorrhage. Brain 134(Pt 5), 1344–
1361. doi: 10.1093/brain/awr052
Derrick, M., Luo, N. L., Bregman, J. C., Jilling, T., Ji, X., Fisher, K., et al. (2004).
Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the
neonatal rabbit: a model for human cerebral palsy? J. Neurosci. 24, 24–34.
doi: 10.1523/JNEUROSCI.2816-03.2004
Descloux, C., Ginet, V., Rummel, C., Truttmann, A. C., and Puyal, J. (2018).
Enhanced autophagy contributes to excitotoxic lesions in a rat model
of preterm brain injury. Cell Death Dis. 9:853. doi: 10.1038/s41419-018-
0916-z
Destot-Wong, K. D., Liang, K., Gupta, S. K., Favrais, G., Schwendimann, L.,
Pansiot, J., et al. (2009). The AMPA receptor positive allosteric modulator,
S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain
damage through BDNF synthesis. Neuropharmacology 57, 277–286. doi: 10.
1016/j.neuropharm.2009.05.010
Dohare, P., Zia, M. T., Ahmed, E., Ahmed, A., Yadala, V., Schober, A. L., et al.
(2016). AMPA-kainate receptor inhibition promotes neurologic recovery in
premature rabbits with intraventricular hemorrhage. J. Neurosci. 36, 3363–3377.
doi: 10.1523/JNEUROSCI.4329-15.2016
Dommergues, M. A., Plaisant, F., Verney, C., and Gressens, P. (2003). Early
microglial activation following neonatal excitotoxic brain damage in mice: a
potential target for neuroprotection. Neuroscience 121, 619–628. doi: 10.1016/
s0306-4522(03)00558-x
Dribben, W. H., Creeley, C. E., Wang, H. H., Smith, D. J., Farber, N. B., and
Olney, J. W. (2009). High dose magnesium sulfate exposure induces apoptotic
cell death in the developing neonatal mouse brain. Neonatology 96, 23–32.
doi: 10.1159/000201327
Frontiers in Cell and Developmental Biology | www.frontiersin.org 21 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 22
Truttmann et al. Cell Death in Preterm Brain Injury
Drommelschmidt, K., Serdar, M., Bendix, I., Herz, J., Bertling, F., Prager, S.,
et al. (2017). Mesenchymal stem cell-derived extracellular vesicles ameliorate
inflammation-induced preterm brain injury. Brain Behav. Immun. 60, 220–232.
doi: 10.1016/j.bbi.2016.11.011
Dubois, J., Benders, M., Borradori-Tolsa, C., Cachia, A., Lazeyras, F., Ha-Vinh
Leuchter, R., et al. (2008). Primary cortical folding in the human newborn:
an early marker of later functional development. Brain 131(Pt 8), 2028–2041.
doi: 10.1093/brain/awn137
Duerden, E. G., Halani, S., Ng, K., Guo, T., Foong, J., Glass, T. J. A., et al.
(2019). White matter injury predicts disrupted functional connectivity and
microstructure in very preterm born neonates. Neuroimage Clin. 21:101596.
doi: 10.1016/j.nicl.2018.11.006
Dummula, K., Vinukonda, G., Chu, P., Xing, Y., Hu, F., Mailk, S., et al.
(2011). Bone morphogenetic protein inhibition promotes neurological recovery
after intraventricular hemorrhage. J. Neurosci. 31, 12068–12082. doi: 10.1523/
JNEUROSCI.0013-11.2011
Dzietko, M., Boos, V., Sifringer, M., Polley, O., Gerstner, B., Genz, K., et al. (2008).
A critical role for Fas/CD-95 dependent signaling pathways in the pathogenesis
of hyperoxia-induced brain injury. Ann. Neurol. 64, 664–673. doi: 10.1002/ana.
21516
Endesfelder, S., Weichelt, U., Schiller, C., Sifringer, M., Bendix, I., and Buhrer,
C. (2017a). Caffeine protects against anticonvulsant-induced neurotoxicity in
the developing rat brain. Neurotox. Res. 32, 460–472. doi: 10.1007/s12640-017-
9768-z
Endesfelder, S., Weichelt, U., Strauss, E., Schlor, A., Sifringer, M., Scheuer, T.,
et al. (2017b). Neuroprotection by caffeine in hyperoxia-induced neonatal brain
injury. Int. J. Mol. Sci. 18, E187. doi: 10.3390/ijms18010187
Endesfelder, S., Zaak, I., Weichelt, U., Buhrer, C., and Schmitz, T. (2014). Caffeine
protects neuronal cells against injury caused by hyperoxia in the immature
brain. Free Radic. Biol. Med. 67, 221–234. doi: 10.1016/j.freeradbiomed.2013.
09.026
Fan, L. W., Kaizaki, A., Tien, L. T., Pang, Y., Tanaka, S., Numazawa, S., et al. (2013).
Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation
and white matter injury in the neonatal rats. Neuroscience 240, 27–38. doi:
10.1016/j.neuroscience.2013.02.041
Fan, L. W., Pang, Y., Lin, S., Rhodes, P. G., and Cai, Z. (2005a). Minocycline
attenuates lipopolysaccharide-induced white matter injury in the
neonatal rat brain. Neurosci 133, 159–168. doi: 10.1111/j.1460-9568.2006.
04918.x
Fan, L. W., Pang, Y., Lin, S., Tien, L. T., Ma, T., Rhodes, P. G., et al. (2005b).
Minocycline reduces lipopolysaccharide-induced neurological dysfunction and
brain injury in the neonatal rat. J. Neurosci. Res. 82, 71–82. doi: 10.1002/jnr.
20623
Felderhoff-Mueser, U., Buhrer, C., Groneck, P., Obladen, M., Bartmann, P., and
Heep, A. (2003). Soluble Fas (CD95/Apo-1), soluble Fas ligand, and activated
caspase 3 in the cerebrospinal fluid of infants with posthemorrhagic and
nonhemorrhagic hydrocephalus. Pediatr. Res. 54, 659–664. doi: 10.1203/01.
PDR.0000084114.83724.65
Felderhoff-Mueser, U., Sifringer, M., Polley, O., Dzietko, M., Leineweber, B.,
Mahler, L., et al. (2005). Caspase-1-processed interleukins in hyperoxia-induced
cell death in the developing brain. Ann. Neurol. 57, 50–59. doi: 10.1002/ana.
20322
Filan, P. M., Hunt, R. W., Anderson, P. J., Doyle, L. W., and Inder, T. E. (2012).
Neurologic outcomes in very preterm infants undergoing surgery. J. Pediatr.
160, 409–414. doi: 10.1016/j.jpeds.2011.09.009
Follett, P. L., Rosenberg, P. A., Volpe, J. J., and Jensen, F. E. (2000). NBQX
attenuates excitotoxic injury in developing white matter. J. Neurosci. 20, 9235–
9241. doi: 10.1523/jneurosci.20-24-09235.2000
Fontaine, R. H., Olivier, P., Massonneau, V., Leroux, P., Degos, V., Lebon, S., et al.
(2008). Vulnerability of white matter towards antenatal hypoxia is linked to a
species-dependent regulation of glutamate receptor subunits. Proc. Natl. Acad.
Sci. U.S.A. 105, 16779–16784. doi: 10.1073/pnas.0803004105
Friedrichs-Maeder, C. L., Griffa, A., Schneider, J., Huppi, P. S., Truttmann, A., and
Hagmann, P. (2017). Exploring the role of white matter connectivity in cortex
maturation. PLoS One 12:e0177466. doi: 10.1371/journal.pone.0177466
Galluzzi, L., Kepp, O., Chan, F. K., and Kroemer, G. (2017). Necroptosis:
mechanisms and relevance to disease. Annu. Rev. Pathol. 12, 103–130. doi:
10.1146/annurev-pathol-052016-100247
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P.,
et al. (2018). Molecular mechanisms of cell death: recommendations of the
nomenclature committee on cell death 2018. Cell Death Differ. 25, 486–541.
doi: 10.1038/s41418-017-0012-4
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H.,
Blagosklonny, M. V., et al. (2012). Molecular definitions of cell death
subroutines: recommendations of the nomenclature committee on cell death
2012. Cell Death Differ. 19, 107–120. doi: 10.1038/cdd.2011.96
Gelot, A., Villapol, S., Billette, de Villemeur, T., Renolleau, S., and Charriaut-
Marlangue, C. (2009). Astrocytic demise in the developing rat and human
brain after hypoxic-ischemic damage. Dev. Neurosci. 31, 459–470. doi: 10.1159/
000232564
Georgiadis, P., Xu, H., Chua, C., Hu, F., Collins, L., Huynh, C., et al. (2008).
Characterization of acute brain injuries and neurobehavioral profiles in a rabbit
model of germinal matrix hemorrhage. Stroke 39, 3378–3388. doi: 10.1161/
STROKEAHA.107.510883
Gerstner, B., Buhrer, C., Rheinlander, C., Polley, O., Schuller, A., Berns, M., et al.
(2006). Maturation-dependent oligodendrocyte apoptosis caused by hyperoxia.
J. Neurosci. Res. 84, 306–315. doi: 10.1002/jnr.20880
Gerstner, B., Sifringer, M., Dzietko, M., Schuller, A., Lee, J., Simons, S., et al.
(2007). Estradiol attenuates hyperoxia-induced cell death in the developing
white matter. Ann. Neurol. 61, 562–573. doi: 10.1002/ana.21118
Gilles, F., Gressens, P., Dammann, O., and Leviton, A. (2017). Hypoxia-ischemia is
not an antecedent of most preterm brain damage: the illusion of validity. Dev.
Med. Child Neurol. 60, 120–125. doi: 10.1111/dmcn.13483
Ginet, V., Pittet, M. P., Rummel, C., Osterheld, M. C., Meuli, R., Clarke, P. G., et al.
(2014a). Dying neurons in thalamus of asphyxiated term newborns and rats are
autophagic. Ann. Neurol. 76, 695–711. doi: 10.1002/ana.24257
Ginet, V., Puyal, J., Clarke, P. G., and Truttmann, A. C. (2009a). Enhancement
of autophagic flux after neonatal cerebral hypoxia-ischemia and its region-
specific relationship to apoptotic mechanisms. Am. J. Pathol. 175, 1962–1974.
doi: 10.2353/ajpath.2009.090463
Ginet, V., Puyal, J., Magnin, G., Clarke, P. G., and Truttmann, A. C. (2009b).
Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model
of cerebral hypoxia-ischemia. J. Neurochem. 108, 552–562. doi: 10.1111/j.1471-
4159.2008.05797.x
Ginet, V., Spiehlmann, A., Rummel, C., Rudinskiy, N., Grishchuk, Y., Luthi-Carter,
R., et al. (2014b). Involvement of autophagy in hypoxic-excitotoxic neuronal
death. Autophagy 10, 846–860. doi: 10.4161/auto.28264
Ginet, V., van de Looij, Y., Petrenko, V., Toulotte, A., Kiss, J., Huppi, P. S., et al.
(2016). Lactoferrin during lactation reduces lipopolysaccharide-induced brain
injury. Biofactors 42, 323–336. doi: 10.1002/biof.1278
Golstein, P., and Kroemer, G. (2007). Cell death by necrosis: towards a molecular
definition. Trends Biochem. Sci. 32, 37–43. doi: 10.1016/j.tibs.2006.11.001
Goni-de-Cerio, F., Alvarez, A., Caballero, A., Mielgo, V. E., Alvarez, F. J., Rey-
Santano, M. C., et al. (2007). Early cell death in the brain of fetal preterm lambs
after hypoxic-ischemic injury. Brain Res. 1151, 161–171. doi: 10.1016/j.brainres.
2007.03.013
Goren, B., Cakir, A., Sevinc, C., Serter Kocoglu, S., Ocalan, B., Oy, C., et al.
(2017). Uridine treatment protects against neonatal brain damage and long-
term cognitive deficits caused by hyperoxia. Brain Res. 1676, 57–68. doi: 10.
1016/j.brainres.2017.09.010
Gozdas, E., Parikh, N. A., Merhar, S. L., Tkach, J. A., He, L., and Holland, S. K.
(2018). Altered functional network connectivity in preterm infants: antecedents
of cognitive and motor impairments? Brain Struct. Funct. 223, 3665–3680.
doi: 10.1007/s00429-018-1707-0
Graham, E. M., Holcroft, C. J., Rai, K. K., Donohue, P. K., and Allen, M. C. (2004).
Neonatal cerebral white matter injury in preterm infants is associated with
culture positive infections and only rarely with metabolic acidosis. Am. J. Obstet.
Gynecol. 191, 1305–1310. doi: 10.1016/j.ajog.2004.06.058
Gram, M., Sveinsdottir, S., Cinthio, M., Sveinsdottir, K., Hansson, S. R., Morgelin,
M., et al. (2014). Extracellular hemoglobin - mediator of inflammation
and cell death in the choroid plexus following preterm intraventricular
hemorrhage. J. Neuroinflammation 11:200. doi: 10.1186/s12974-014-
0200-9
Griesmaier, E., Schlager, G., Wegleiter, K., Hermann, M., Urbanek, M., Simbruner,
G., et al. (2010). Role of p75NTR in NMDAR-mediated excitotoxic brain injury
in neonatal mice. Brain Res. 1355, 31–40. doi: 10.1016/j.brainres.2010.07.095
Frontiers in Cell and Developmental Biology | www.frontiersin.org 22 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 23
Truttmann et al. Cell Death in Preterm Brain Injury
Grishchuk, Y., Ginet, V., Truttmann, A. C., Clarke, P. G., and Puyal, J. (2011).
Beclin 1-independent autophagy contributes to apoptosis in cortical neurons.
Autophagy 7, 1115–1131. doi: 10.4161/auto.7.10.16608
Gussenhoven, R., Westerlaken, R. J. J., Ophelders, D., Jobe, A. H., Kemp, M. W.,
Kallapur, S. G., et al. (2018). Chorioamnionitis, neuroinflammation, and injury:
timing is key in the preterm ovine fetus. J. Neuroinflammation 15:113. doi:
10.1186/s12974-018-1149-x
Hagberg, H., Mallard, C., Ferriero, D. M., Vannucci, S. J., Levison, S. W., Vexler,
Z. S., et al. (2015). The role of inflammation in perinatal brain injury. Nat. Rev.
Neurol. 11, 192–208. doi: 10.1038/nrneurol.2015.13
Hagen, M. W., Riddle, A., McClendon, E., Gong, X., Shaver, D., Srivastava, T.,
et al. (2014). Role of recurrent hypoxia-ischemia in preterm white matter injury
severity. PLoS One 9:e112800. doi: 10.1371/journal.pone.0112800
Haldipur, P., Dupuis, N., Degos, V., Moniaux, N., Chhor, V., Rasika, S., et al. (2014).
HIP/PAP prevents excitotoxic neuronal death and promotes plasticity. Ann.
Clin. Transl. Neurol. 1, 739–754. doi: 10.1002/acn3.127
Hargitai, B., Szabo, V., Hajdu, J., Harmath, A., Pataki, M., Farid, P., et al. (2001).
Apoptosis in various organs of preterm infants: histopathologic study of lung,
kidney, liver, and brain of ventilated infants. Pediatr. Res. 50, 110–114. doi:
10.1203/00006450-200107000-00020
Haynes, R. L., Billiards, S. S., Borenstein, N. S., Volpe, J. J., and Kinney, H. C.
(2008). Diffuse axonal injury in periventricular leukomalacia as determined
by apoptotic marker fractin. Pediatr. Res. 63, 656–661. doi: 10.1203/PDR.
0b013e31816c825c
Haynes, R. L., Folkerth, R. D., Keefe, R. J., Sung, I., Swzeda, L. I., Rosenberg,
P. A., et al. (2003). Nitrosative and oxidative injury to premyelinating
oligodendrocytes in periventricular leukomalacia. J. Neuropathol. Exp. Neurol.
62, 441–450. doi: 10.1093/jnen/62.5.441
Haynes, R. L., and van Leyen, K. (2013). 12/15-lipoxygenase expression is
increased in oligodendrocytes and microglia of periventricular leukomalacia.
Dev. Neurosci. 35, 140–154. doi: 10.1159/000350230
Heo, J. S., Kim, E. K., Choi, Y. H., Shin, S. H., Sohn, J. A., Cheon, J. E., et al.
(2018). Timing of sepsis is an important risk factor for white matter abnormality
in extremely premature infants with sepsis. Pediatr. Neonatol. 59, 77–84. doi:
10.1016/j.pedneo.2017.07.008
Hielkema, T., and Hadders-Algra, M. (2016). Motor and cognitive outcome after
specific early lesions of the brain - a systematic review. Dev. Med. Child Neurol.
58(Suppl. 4), 46–52. doi: 10.1111/dmcn.13047
Hoeber, D., Sifringer, M., van de Looij, Y., Herz, J., Sizonenko, S. V., Kempe,
K., et al. (2016). Erythropoietin restores long-term neurocognitive function
involving mechanisms of neuronal plasticity in a model of hyperoxia-induced
preterm brain injury. Oxid. Med. Cell Longev. 2016:9247493. doi: 10.1155/2016/
9247493
Huang, Y., Lai, H., Xu, H., Wu, W., Lai, X., Ho, G., et al. (2013). Impact of
perinatal systemic hypoxic-ischemic injury on the brain of male offspring rats:
an improved model of neonatal hypoxic-ischemic encephalopathy in early
preterm newborns. PLoS One 8:e82502. doi: 10.1371/journal.pone.0082502
Husson, I., Mesplès, B., Bac, P., Vamecq, J., Evrard, P., and Gressens, P. (2002).
Melatoninergic neuroprotection of the murine periventricular white matter
against neonatal excitotoxic challenge. Ann. Neurol. 51, 82–92. doi: 10.1002/
ana.10072
Husson, I., Rangon, C. M., Lelievre, V., Bemelmans, A. P., Sachs, P., Mallet, J., et al.
(2005). BDNF-induced white matter neuroprotection and stage-dependent
neuronal survival following a neonatal excitotoxic challenge. Cereb. Cortex 15,
250–261. doi: 10.1093/cercor/bhh127
Ikebara, J. M., Takada, S. H., Cardoso, D. S., Dias, N. M., de Campos, B. C.,
Bretherick, T. A., et al. (2017). Functional role of intracellular calcium receptor
inositol 1,4,5-trisphosphate type 1 in rat hippocampus after neonatal anoxia.
PLoS One 12:e0169861. doi: 10.1371/journal.pone.0169861
Jablonska, B., Scafidi, J., Aguirre, A., Vaccarino, F., Nguyen, V., Borok, E., et al.
(2012). Oligodendrocyte regeneration after neonatal hypoxia requires FoxO1-
mediated p27Kip1 expression. J. Neurosci. 32, 14775–14793. doi: 10.1523/
JNEUROSCI.2060-12.2012
Jakab, A., Ruegger, C., Bucher, H. U., Makki, M., Huppi, P. S., Tuura, R.,
et al. (2019). Network based statistics reveals trophic and neuroprotective
effect of early high dose erythropoetin on brain connectivity in very
preterm infants. Neuroimage Clin. 22:101806. doi: 10.1016/j.nicl.2019.10
1806
Jantzie, L. L., Corbett, C. J., Firl, D. J., and Robinson, S. (2015a). Postnatal
erythropoietin mitigates impaired cerebral cortical development following
subplate loss from prenatal hypoxia-ischemia. Cereb. Cortex 25, 2683–2695.
doi: 10.1093/cercor/bhu066
Jantzie, L. L., and Robinson, S. (2015). Preclinical models of encephalopathy of
prematurity. Dev. Neurosci. 37, 277–288. doi: 10.1159/000371721
Jantzie, L. L., Talos, D. M., Jackson, M. C., Park, H. K., Graham, D. A., Lechpammer,
M., et al. (2015b). Developmental expression of N-methyl-D-aspartate (n.d.)
receptor subunits in human white and gray matter: potential mechanism of
increased vulnerability in the immature brain. Cereb. Cortex 25, 482–495. doi:
10.1093/cercor/bht246
Kaindl, A. M., Sifringer, M., Koppelstaetter, A., Genz, K., Loeber, R., Boerner, C.,
et al. (2008). Erythropoietin protects the developing brain from hyperoxia-
induced cell death and proteome changes. Ann. Neurol. 64, 523–534. doi: 10.
1002/ana.21471
Kersbergen, K. J., Leroy, F., Isgum, I., Groenendaal, F., de Vries, L. S., Claessens,
N. H. P., et al. (2016). Relation between clinical risk factors, early cortical
changes, and neurodevelopmental outcome in preterm infants. Neuroimage
142, 301–310. doi: 10.1016/j.neuroimage.2016.07.010
Kida, H., Nomura, S., Shinoyama, M., Ideguchi, M., Owada, Y., and Suzuki,
M. (2013). The effect of hypothermia therapy on cortical laminar disruption
following ischemic injury in neonatal mice. PLoS One 8:e68877. doi: 10.1371/
journal.pone.0068877
Kidokoro, H., Anderson, P. J., Doyle, L. W., Woodward, L. J., Neil, J. J., and Inder,
T. E. (2014). Brain injury and altered brain growth in preterm infants: predictors
and prognosis. Pediatrics 134, e444–e453. doi: 10.1542/peds.2013-2336
Kidokoro, H., Neil, J. J., and Inder, T. E. (2013). New MR imaging assessment
tool to define brain abnormalities in very preterm infants at term. AJNR Am.
J. Neuroradiol. 34, 2208–2214. doi: 10.3174/ajnr.A3521
Kinney, H. C., Haynes, R. L., Xu, G., Andiman, S. E., Folkerth, R. D., Sleeper, L. A.,
et al. (2012). Neuron deficit in the white matter and subplate in periventricular
leukomalacia. Ann. Neurol. 71, 397–406. doi: 10.1002/ana.22612
Kinney, H. C., and Volpe, J. J. (2012). Modeling the encephalopathy of prematurity
in animals: the important role of translational research. Neurol. Res. Int.
2012:295389. doi: 10.1155/2012/295389
Kitanaka, C., and Kuchino, Y. (1999). Caspase-independent programmed cell
death with necrotic morphology. Cell Death Differ. 6, 508–515. doi: 10.1038/
sj.cdd.4400526
Klebe, D., McBride, D., Krafft, P. R., Flores, J. J., Tang, J., and Zhang, J. H.
(2020). Posthemorrhagic hydrocephalus development after germinal matrix
hemorrhage: established mechanisms and proposed pathways. J. Neurosci. Res.
98, 105–120. doi: 10.1002/jnr.24394
Klionsky, D. J., Abdelmohsen, K., Abe, A., Abedin, M. J., Abeliovich, H., Acevedo
Arozena, A., et al. (2016). Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy 12, 1–222. doi: 10.1080/
15548627.2015.1100356
Kodama, M., Satoh, Y., Otsubo, Y., Araki, Y., Yonamine, R., Masui, K., et al. (2011).
Neonatal desflurane exposure induces more robust neuroapoptosis than do
isoflurane and sevoflurane and impairs working memory. Anesthesiology 115,
979–991. doi: 10.1097/ALN.0b013e318234228b
Kriel, J., and Loos, B. (2019). The good, the bad and the autophagosome: exploring
unanswered questions of autophagy-dependent cell death. Cell Death Differ. 26,
640–652. doi: 10.1038/s41418-018-0267-4
Kroemer, G., and Levine, B. (2008). Autophagic cell death: the story of a misnomer.
Nat. Rev. Mol. Cell Biol. 9, 1004–1010. doi: 10.1038/nrm2529
Kumral, A., Baskin, H., Yesilirmak, D. C., Ergur, B. U., Aykan, S., Genc, S., et al.
(2007). Erythropoietin attenuates lipopolysaccharide-induced white matter
injury in the neonatal rat brain. Neonatology 92, 269–278. doi: 10.1159/
000105493
Kumral, A., Iscan, B., Engur, D., Tuzun, F., Ozbal, S., Ergur, B. U., et al. (2017).
Intranasal surfactant protein D as neuroprotective rescue in a neonatal rat
model of periventricular leukomalacia. J. Matern. Fetal. Neonatal. Med. 30,
446–451. doi: 10.1080/14767058.2016.1174996
Kurul, S. H., Yis, U., Kumral, A., Tugyan, K., Cilaker, S., Kolatan, E., et al. (2009).
Protective effects of topiramate against hyperoxic brain injury in the developing
brain. Neuropediatrics 40, 22–27. doi: 10.1055/s-0029-1224101
Levine, B., and Kroemer, G. (2019). Biological functions of autophagy genes: a
disease perspective. Cell 176, 11–42. doi: 10.1016/j.cell.2018.09.048
Frontiers in Cell and Developmental Biology | www.frontiersin.org 23 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 24
Truttmann et al. Cell Death in Preterm Brain Injury
Li, J., Xiong, M., Nadavaluru, P. R., Zuo, W., Ye, J. H., Eloy, J. D., et al.
(2016a). Dexmedetomidine attenuates neurotoxicity induced by prenatal
propofol exposure. J. Neurosurg. Anesthesiol. 28, 51–64. doi: 10.1097/ANA.
0000000000000181
Li, J., Yawno, T., Sutherland, A., Loose, J., Nitsos, I., Allison, B. J., et al. (2017). Term
vs. preterm cord blood cells for the prevention of preterm brain injury. Pediatr.
Res. 82, 1030–1038. doi: 10.1038/pr.2017.170
Li, J., Yawno, T., Sutherland, A., Loose, J., Nitsos, I., Bischof, R., et al. (2016b).
Preterm white matter brain injury is prevented by early administration of
umbilical cord blood cells. Exp. Neurol. 283(Pt A), 179–187. doi: 10.1016/j.
expneurol.2016.06.017
Li, X., Wu, Z., Zhang, Y., Xu, Y., Han, G., and Zhao, P. (2017). Activation of
autophagy contributes to sevoflurane-induced neurotoxicity in fetal rats. Front.
Mol. Neurosci. 10:432. doi: 10.3389/fnmol.2017.00432
Ligam, P., Haynes, R. L., Folkerth, R. D., Liu, L., Yang, M., Volpe, J. J., et al.
(2009). Thalamic damage in periventricular leukomalacia: novel pathologic
observations relevant to cognitive deficits in survivors of prematurity. Pediatr.
Res. 65, 524–529. doi: 10.1203/PDR.0b013e3181998baf
Liu, Y., Shoji-Kawata, S., Sumpter, RM Jr, Wei, Y., Ginet, V., Zhang, L., et al.
(2013). Autosis is a Na+,K+-ATPase-regulated form of cell death triggered
by autophagy-inducing peptides, starvation, and hypoxia-ischemia. Proc. Natl.
Acad. Sci. U.S.A. 110, 20364–20371. doi: 10.1073/pnas.1319661110
Lodygensky, G. A., Kunz, N., Perroud, E., Somm, E., Mlynarik, V., Huppi, P. S.,
et al. (2014). Definition and quantification of acute inflammatory white matter
injury in the immature brain by MRI/MRS at high magnetic field. Pediatr. Res.
75, 415–423. doi: 10.1038/pr.2013.242
Luyt, K., Jary, S., Lea, C., Young, G. J., Odd, D., Miller, H., et al. (2019). Ten-
year follow-up of a randomised trial of drainage, irrigation and fibrinolytic
therapy (DRIFT) in infants with post-haemorrhagic ventricular dilatation.
Health Technol. Assess. 23, 1–116. doi: 10.3310/hta23040
Mallard, C., Welin, A. K., Peebles, D., Hagberg, H., and Kjellmer, I. (2003). White
matter injury following systemic endotoxemia or asphyxia in the fetal sheep.
Neurochem. Res. 28, 215–223. doi: 10.1023/a:1022368915400
Marino, G., Madeo, F., and Kroemer, G. (2011). Autophagy for tissue homeostasis
and neuroprotection. Curr. Opin. Cell Biol. 23, 198–206. doi: 10.1016/j.ceb.2010.
10.001
Mazur, M., Miller, R. H., and Robinson, S. (2010). Postnatal erythropoietin
treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic
injury. J. Neurosurg. Pediatr. 6, 206–221. doi: 10.3171/2010.5.PEDS1032
McClendon, E., Shaver, D. C., Degener-O’Brien, K., Gong, X., Nguyen, T., Hoerder-
Suabedissen, A., et al. (2017). Transient hypoxemia chronically disrupts
maturation of preterm fetal ovine subplate neuron arborization and activity.
J. Neurosci. 37, 11912–11929. doi: 10.1523/JNEUROSCI.2396-17.2017
McGowan, E. C., and Vohr, B. R. (2019). Neurodevelopmental follow-up of
preterm infants: what is new? Pediatr. Clin. North Am. 66, 509–523. doi: 10.
1016/j.pcl.2018.12.015
McPherson, C., Neil, J. J., Tjoeng, T. H., Pineda, R., and Inder, T. E. (2015). A pilot
randomized trial of high-dose caffeine therapy in preterm infants. Pediatr. Res.
78, 198–204. doi: 10.1038/pr.2015.72
McQuillen, P. S., Sheldon, R. A., Shatz, C. J., and Ferriero, D. M. (2003).
Selective vulnerability of subplate neurons after early neonatal hypoxia-
ischemia. J. Neurosci. 23, 3308–3315. doi: 10.1523/jneurosci.23-08-03308.2003
Medja, F., Lelievre, V., Fontaine, R. H., Lebas, F., Leroux, P., Ouimet, T., et al.
(2006). Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is
neuroprotective in newborn mice. Brain 129(Pt 12), 3209–3223. doi: 10.1093/
brain/awl239
Mikhailova, A., Sunkara, N., and McQuillen, P. S. (2017). Unbiased quantification
of subplate neuron loss following neonatal hypoxia-ischemia in a rat model.
Dev. Neurosci. 39, 171–181. doi: 10.1159/000460815
Morriss, FH Jr, Saha, S., Bell, E. F., Colaizy, T. T., Stoll, B. J., Hintz, S. R., et al.
(2014). Surgery and neurodevelopmental outcome of very low-birth-weight
infants. JAMA Pediatr. 168, 746–754. doi: 10.1001/jamapediatrics.2014.307
Mukai, T., Mori, Y., Shimazu, T., Takahashi, A., Tsunoda, H., Yamaguchi, S.,
et al. (2017). Intravenous injection of umbilical cord-derived mesenchymal
stromal cells attenuates reactive gliosis and hypomyelination in a neonatal
intraventricular hemorrhage model. Neuroscience 355, 175–187. doi: 10.1016/
j.neuroscience.2017.05.006
Neubauer, V., Wegleiter, K., Posod, A., Urbanek, M., Wechselberger, K., Kiechl-
Kohlendorfer, U., et al. (2016). Delayed application of the haematopoietic
growth factors G-CSF/SCF and FL reduces neonatal excitotoxic brain injury.
Brain Res. 1634, 94–103. doi: 10.1016/j.brainres.2015.12.058
Noguchi, K. K., Johnson, S. A., Manzella, F. M., Masuoka, K. L., Williams, S. L.,
Martin, L. D., et al. (2018). Caffeine augments anesthesia neurotoxicity in the
fetal macaque brain. Sci. Rep. 8:5302. doi: 10.1038/s41598-018-23560-7
Northington, F. J., Chavez-Valdez, R., and Martin, L. J. (2011). Neuronal cell
death in neonatal hypoxia-ischemia. Ann. Neurol. 69, 743–758. doi: 10.1002/
ana.22419
Nossin-Manor, R., Card, D., Morris, D., Noormohamed, S., Shroff, M. M., Whyte,
H. E., et al. (2013). Quantitative MRI in the very preterm brain: assessing tissue
organization and myelination using magnetization transfer, diffusion tensor
and T(1) imaging. Neuroimage 64, 505–516. doi: 10.1016/j.neuroimage.2012.08.
086
Okusa, C., Oeschger, F., Ginet, V., Wang, W. Z., Hoerder-Suabedissen, A.,
Matsuyama, T., et al. (2014). Subplate in a rat model of preterm hypoxia-
ischemia. Ann. Clin. Transl. Neurol. 1, 679–691. doi: 10.1002/acn3.97
Paintlia, M. K., Paintlia, A. S., Barbosa, E., Singh, I., and Singh, A. K. (2004).
N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte
progenitors and hypomyelination in developing rat brain. J. Neurosci. Res. 78,
347–361. doi: 10.1002/jnr.20261
Panda, S., Dohare, P., Jain, S., Parikh, N., Singla, P., Mehdizadeh, R., et al.
(2018). Estrogen treatment reverses prematurity-induced disruption in cortical
interneuron population. J. Neurosci. 38, 7378–7391. doi: 10.1523/JNEUROSCI.
0478-18.2018
Paneth, N. (2018). Hypoxia-ischemia and brain injury in infants born preterm. Dev.
Med. Child Neurol. 60:115. doi: 10.1111/dmcn.13642
Panfoli, I., Candiano, G., Malova, M., De Angelis, L., Cardiello, V., Buonocore,
G., et al. (2018). Oxidative stress as a primary risk factor for brain damage in
preterm newborns. Front. Pediatr. 6:369. doi: 10.3389/fped.2018.00369
Paton, M. C. B., Allison, B. J., Li, J., Fahey, M. C., Sutherland, A. E., Nitsos, I., et al.
(2018). Human umbilical cord blood therapy protects cerebral white matter
from systemic LPS exposure in preterm fetal sheep. Dev. Neurosci. 40, 258–270.
doi: 10.1159/000490943
Pham, H., Vottier, G., Pansiot, J., Duong-Quy, S., Bollen, B., Dalous, J., et al. (2014).
Inhaled NO prevents hyperoxia-induced white matter damage in neonatal rats.
Exp. Neurol. 252, 114–123. doi: 10.1016/j.expneurol.2013.11.025
Pierrat, V., Marchand-Martin, L., Arnaud, C., Kaminski, M., Resche-Rigon, M.,
Lebeaux, C., et al. (2017). Neurodevelopmental outcome at 2 years for preterm
children born at 22 to 34 weeks’ gestation in France in 2011: EPIPAGE-2 cohort
study. BMJ 358:j3448. doi: 10.1136/bmj.j3448
Pierre, W. C., Akakpo, L., Londono, I., Pouliot, P., Chemtob, S., Lesage, F., et al.
(2019). Assessing therapeutic response non-invasively in a neonatal rat model
of acute inflammatory white matter injury using high-field MRI. Brain Behav.
Immun. 81, 348–360. doi: 10.1016/j.bbi.2019.06.032
Pierson, C. R., Folkerth, R. D., Billiards, S. S., Trachtenberg, F. L., Drinkwater, M. E.,
Volpe, J. J., et al. (2007). Gray matter injury associated with periventricular
leukomalacia in the premature infant. Acta Neuropathol. 114, 619–631. doi:
10.1007/s00401-007-0295-5
Portera-Cailliau, C., Price, D. L., and Martin, L. J. (1997). Excitotoxic
neuronal death in the immature brain is an apoptosis-necrosis morphological
continuum. J. Comp. Neurol. 378, 70–87.
Posod, A., Pinzer, K., Urbanek, M., Wegleiter, K., Keller, M., Kiechl-Kohlendorfer,
U., et al. (2014). The common antitussive agent dextromethorphan protects
against hyperoxia-induced cell death in established in vivo and in vitro
models of neonatal brain injury. Neuroscience 274, 260–272. doi: 10.1016/j.
neuroscience.2014.05.059
Puyal, J., Ginet, V., and Clarke, P. G. (2013). Multiple interacting cell death
mechanisms in the mediation of excitotoxicity and ischemic brain damage:
a challenge for neuroprotection. Prog. Neurobiol. 105, 24–48. doi: 10.1016/j.
pneurobio.2013.03.002
Puyal, J., Vaslin, A., Mottier, V., and Clarke, P. G. (2009). Postischemic treatment of
neonatal cerebral ischemia should target autophagy. Ann. Neurol. 66, 378–389.
doi: 10.1002/ana.21714
Riddle, A., Luo, N. L., Manese, M., Beardsley, D. J., Green, L., Rorvik, D. A.,
et al. (2006). Spatial heterogeneity in oligodendrocyte lineage maturation and
Frontiers in Cell and Developmental Biology | www.frontiersin.org 24 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 25
Truttmann et al. Cell Death in Preterm Brain Injury
not cerebral blood flow predicts fetal ovine periventricular white matter injury.
J. Neurosci. 26, 3045–3055. doi: 10.1523/JNEUROSCI.5200-05.2006
Riedl, S. J., and Shi, Y. (2004). Molecular mechanisms of caspase regulation during
apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897–907. doi: 10.1038/nrm1496
Robinson, S., Li, Q., Dechant, A., and Cohen, M. L. (2006). Neonatal loss of
gamma-aminobutyric acid pathway expression after human perinatal brain
injury. J. Neurosurg/ 104 6(Suppl.), 396–408. doi: 10.3171/ped.2006.104.6.396
Robinson, S., Petelenz, K., Li, Q., Cohen, M. L., Dechant, A., Tabrizi, N., et al.
(2005). Developmental changes induced by graded prenatal systemic hypoxic-
ischemic insults in rats. Neurobiol. Dis. 18, 568–581. doi: 10.1016/j.nbd.2004.10.
024
Rogido, M., Husson, I., Bonnier, C., Lallemand, M. C., Merienne, C., Gregory,
G. A., et al. (2003). Fructose-1,6-biphosphate prevents excitotoxic neuronal cell
death in the neonatal mouse brain. Brain Res. Dev. Brain Res. 140, 287–297.
doi: 10.1016/s0165-3806(02)00615-6
Rousset, C. I., Chalon, S., Cantagrel, S., Bodard, S., Andres, C., Gressens, P., et al.
(2006). Maternal exposure to LPS induces hypomyelination in the internal
capsule and programmed cell death in the deep gray matter in newborn rats.
Pediatr. Res. 59, 428–433. doi: 10.1203/01.pdr.0000199905.08848.55
Rousset, C. I., Kassem, J., Aubert, A., Planchenault, D., Gressens, P., Chalon,
S., et al. (2013). Maternal exposure to lipopolysaccharide leads to transient
motor dysfunction in neonatal rats. Dev. Neurosci. 35, 172–181. doi: 10.1159/
000346579
Scafidi, J., Hammond, T. R., Scafidi, S., Ritter, J., Jablonska, B., Roncal, M., et al.
(2014). Intranasal epidermal growth factor treatment rescues neonatal brain
injury. Nature 506, 230–234. doi: 10.1038/nature12880
Schaafsma, W., Basterra, L. B., Jacobs, S., Brouwer, N., Meerlo, P., Schaafsma,
A., et al. (2017). Maternal inflammation induces immune activation of fetal
microglia and leads to disrupted microglia immune responses, behavior, and
learning performance in adulthood. Neurobiol. Dis. 106, 291–300. doi: 10.1016/
j.nbd.2017.07.017
Schmidt, A. F., Kannan, P. S., Chougnet, C. A., Danzer, S. C., Miller, L. A., Jobe,
A. H., et al. (2016). Intra-amniotic LPS causes acute neuroinflammation in
preterm rhesus macaques. J. Neuroinflammation 13:238. doi: 10.1186/s12974-
016-0706-4
Schmidt, B., Anderson, P. J., Doyle, L. W., Dewey, D., Grunau, R. E., Asztalos, E. V.,
et al. (2012). Survival without disability to age 5 years after neonatal caffeine
therapy for apnea of prematurity. JAMA 307, 275–282. doi: 10.1001/jama.2011.
2024
Schmidt, B., Roberts, R. S., Anderson, P. J., Asztalos, E. V., Costantini, L., Davis,
P. G., et al. (2017). Academic performance, motor function, and behavior 11
years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year
follow-up of the CAP randomized clinical trial. JAMA Pediatr. 171, 564–572.
doi: 10.1001/jamapediatrics.2017.0238
Schmitz, T., Felderhoff-Mueser, U., Sifringer, M., Groenendaal, F., Kampmann, S.,
and Heep, A. (2011). Expression of soluble Fas in the cerebrospinal fluid of
preterm infants with posthemorrhagic hydrocephalus and cystic white matter
damage. J. Perinat. Med. 39, 83–88. doi: 10.1515/JPM.2010.125
Schmitz, T., Krabbe, G., Weikert, G., Scheuer, T., Matheus, F., Wang, Y., et al.
(2014). Minocycline protects the immature white matter against hyperoxia. Exp.
Neurol. 254, 153–165. doi: 10.1016/j.expneurol.2014.01.017
Schneider, J., Fischer Fumeaux, C. J., Duerden, E. G., Guo, T., Foong, J., Graz,
M. B., et al. (2018). Nutrient Intake in the first two weeks of life and brain
growth in preterm neonates. Pediatrics 141, e20172169. doi: 10.1542/peds.2017-
2169
Schneider, J., Kober, T., Bickle Graz, M., Meuli, R., Huppi, P. S., Hagmann, P.,
et al. (2016). Evolution of T1 relaxation, ADC, and fractional anisotropy during
early brain maturation: a serial imaging study on preterm infants. AJNR Am. J.
Neuroradiol. 37, 155–162. doi: 10.3174/ajnr.A4510
Schneider, J., and Miller, S. P. (2019). Preterm brain Injury: white matter injury.
Handb. Clin. Neurol. 162, 155–172. doi: 10.1016/B978-0-444-64029-1.00007-2
Segovia, K. N., McClure, M., Moravec, M., Luo, N. L., Wan, Y., Gong, X., et al.
(2008). Arrested oligodendrocyte lineage maturation in chronic perinatal white
matter injury. Ann. Neurol. 63, 520–530. doi: 10.1002/ana.21359
Seyama, T., Kamei, Y., Iriyama, T., Imada, S., Ichinose, M., Toshimitsu, M., et al.
(2018). Pretreatment with magnesium sulfate attenuates white matter damage
by preventing cell death of developing oligodendrocytes. J. Obstet. Gynaecol.
Res. 44, 601–607. doi: 10.1111/jog.13568
Shah, D. K., Doyle, L. W., Anderson, P. J., Bear, M., Daley, A. J., Hunt, R. W., et al.
(2008). Adverse neurodevelopment in preterm infants with postnatal sepsis or
necrotizing enterocolitis is mediated by white matter abnormalities on magnetic
resonance imaging at term. J. Pediatr. 153:175.e1–171.e1. doi: 10.1016/j.jpeds.
2008.02.033
Sifringer, M., Bendix, I., Borner, C., Endesfelder, S., von Haefen, C., Kalb,
A., et al. (2012). Prevention of neonatal oxygen-induced brain damage by
reduction of intrinsic apoptosis. Cell Death Dis. 3:e250. doi: 10.1038/cddis.
2011.133
Sifringer, M., von Haefen, C., Krain, M., Paeschke, N., Bendix, I., Buhrer, C.,
et al. (2015). Neuroprotective effect of dexmedetomidine on hyperoxia-induced
toxicity in the neonatal rat brain. Oxid. Med. Cell Longev. 2015:530371. doi:
10.1155/2015/530371
Sinner, B., Becke, K., and Engelhard, K. (2014). General anaesthetics and the
developing brain: an overview. Anaesthesia 69, 1009–1022. doi: 10.1111/anae.
12637
Sokolowska, P., Passemard, S., Mok, A., Schwendimann, L., Gozes, I., and Gressens,
P. (2011). Neuroprotective effects of NAP against excitotoxic brain damage in
the newborn mice: implications for cerebral palsy. Neuroscience 173, 156–168.
doi: 10.1016/j.neuroscience.2010.10.074
Sokolowski, J. D., Gamage, K. K., Heffron, D. S., Leblanc, A. C., Deppmann, C. D.,
and Mandell, J. W. (2014). Caspase-mediated cleavage of actin and tubulin
is a common feature and sensitive marker of axonal degeneration in neural
development and injury. Acta Neuropathol. Commun. 2:16. doi: 10.1186/2051-
5960-2-16
Stolp, H. B., Fleiss, B., Arai, Y., Supramaniam, V., Vontell, R., Birtles, S., et al.
(2019). Interneuron development is disrupted in preterm brains with diffuse
white matter injury: observations in mouse and human. Front. Physiol. 10:955.
doi: 10.3389/fphys.2019.00955
Stolwijk, L. J., Lemmers, P. M., Harmsen, M., Groenendaal, F., de Vries, L. S.,
van der Zee, D. C., et al. (2016). Neurodevelopmental outcomes after neonatal
surgery for major noncardiac anomalies. Pediatrics 137:e20151728. doi: 10.
1542/peds.2015-1728
Stolwijk, L. J., Lemmers, P. M. A., van Herwaarden, M. Y. A., van der Zee,
D. C., van Bel, F., Groenendaal, F., et al. (2017). Predictive role of F2-
isoprostanes as biomarkers for brain damage after neonatal surgery. Dis.
Markers 2017:2728103. doi: 10.1155/2017/2728103
Straley, M. E., Van Oeffelen, W., Theze, S., Sullivan, A. M., O’Mahony, S. M., Cryan,
J. F., et al. (2017). Distinct alterations in motor & reward seeking behavior are
dependent on the gestational age of exposure to LPS-induced maternal immune
activation. Brain Behav. Immun. 63, 21–34. doi: 10.1016/j.bbi.2016.06.002
Sun, L. (2010). Early childhood general anaesthesia exposure and neurocognitive
development. Br. J. Anaesth. 105(Suppl. 1), i61–i68. doi: 10.1093/bja/aeq302
Synnes, A., and Hicks, M. (2018). Neurodevelopmental outcomes of preterm
children at school age and beyond. Clin. Perinatol. 45, 393–408. doi: 10.1016/
j.clp.2018.05.002
Taglialatela, G., Perez-Polo, J. R., and Rassin, D. K. (1998). Induction of apoptosis
in the CNS during development by the combination of hyperoxia and inhibition
of glutathione synthesis. Free Radic Biol. Med 25, 936–942. doi: 10.1016/s0891-
5849(98)00131-2
Tahraoui, S. L., Marret, S., Bodenant, C., Leroux, P., Dommergues, M. A., Evrard,
P., et al. (2001). Central role of microglia in neonatal excitotoxic lesions of the
murine periventricular white matter. Brain Pathol. 11, 56–71. doi: 10.1111/j.
1750-3639.2001.tb00381.x
Takada, S. H., dos Santos Haemmerle, C. A., Motta-Teixeira, L. C., Machado-
Nils, A. V., Lee, V. Y., Takase, L. F., et al. (2015). Neonatal anoxia in rats:
hippocampal cellular and subcellular changes related to cell death and spatial
memory. Neuroscience 284, 247–259. doi: 10.1016/j.neuroscience.2014.08.054
van de Looij, Y., Ginet, V., Chatagner, A., Toulotte, A., Somm, E., Huppi, P. S.,
et al. (2014). Lactoferrin during lactation protects the immature hypoxic-
ischemic rat brain. Ann. Clin. Transl. Neurol. 1, 955–967. doi: 10.1002/acn
3.138
Van’t Hooft, J., van der Lee, J. H., Opmeer, B. C., Aarnoudse-Moens, C. S.,
Leenders, A. G., Mol, B. W., et al. (2015). Predicting developmental outcomes
in premature infants by term equivalent MRI: systematic review and meta-
analysis. Syst. Rev. 4:71. doi: 10.1186/s13643-015-0058-7
Verney, C., Pogledic, I., Biran, V., Adle-Biassette, H., Fallet-Bianco, C., and
Gressens, P. (2012). Microglial reaction in axonal crossroads is a hallmark
Frontiers in Cell and Developmental Biology | www.frontiersin.org 25 February 2020 | Volume 8 | Article 27
fcell-08-00027 February 15, 2020 Time: 17:4 # 26
Truttmann et al. Cell Death in Preterm Brain Injury
of noncystic periventricular white matter injury in very preterm infants.
J. Neuropathol. Exp. Neurol. 71, 251–264. doi: 10.1097/NEN.0b013e3182496429
Vinukonda, G., Csiszar, A., Hu, F., Dummula, K., Pandey, N. K., Zia, M. T., et al.
(2010). Neuroprotection in a rabbit model of intraventricular haemorrhage
by cyclooxygenase-2, prostanoid receptor-1 or tumour necrosis factor-alpha
inhibition. Brain 133(Pt 8), 2264–2280. doi: 10.1093/brain/awq107
Vontell, R., Supramaniam, V., Wyatt-Ashmead, J., Gressens, P., Rutherford,
M., Hagberg, H., et al. (2015). Cellular mechanisms of toll-like receptor-3
activation in the thalamus are associated with white matter injury in the
developing brain. J. Neuropathol. Exp. Neurol. 74, 273–285. doi: 10.1097/NEN.
0000000000000172
Vottier, G., Pham, H., Pansiot, J., Biran, V., Gressens, P., Charriaut-Marlangue,
C., et al. (2011). Deleterious effect of hyperoxia at birth on white matter
damage in the newborn rat. Dev. Neurosci. 33, 261–269. doi: 10.1159/00032
7245)
Walker, S. M., Melbourne, A., O’Reilly, H., Beckmann, J., Eaton-Rosen, Z.,
Ourselin, S., et al. (2018). Somatosensory function and pain in extremely
preterm young adults from the UK EPICure cohort: sex-dependent differences
and impact of neonatal surgery. Br. J. Anaesth. 121, 623–635. doi: 10.1016/j.bja.
2018.03.035
Wang, L. W., Chang, Y. C., Lin, C. Y., Hong, J. S., and Huang, C. C. (2010). Low-
dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white
matter injury in the immature brain. Pediatr. Res. 68, 41–47. doi: 10.1203/
00006450-201011001-00076
Wang, L. W., Tu, Y. F., Huang, C. C., and Ho, C. J. (2012). JNK signaling
is the shared pathway linking neuroinflammation, blood-brain barrier
disruption, and oligodendroglial apoptosis in the white matter injury of
the immature brain. J. Neuroinflammation 9:175. doi: 10.1186/1742-2094-
9-175
Wang, X., Dong, Y., Zhang, Y., Li, T., and Xie, Z. (2019). Sevoflurane induces
cognitive impairment in young mice via autophagy. PLoS One 14:e0216372.
doi: 10.1371/journal.pone.0216372
Wang, Y., Wang, C., Zhang, Y., Wang, G., and Yang, H. (2019). Pre-administration
of luteoline attenuates neonatal sevoflurane-induced neurotoxicity in mice.
Acta Histochem. 121, 500–507. doi: 10.1016/j.acthis.2019.04.004
Wassink, G., Davidson, J. O., Dhillon, S. K., Fraser, M., Galinsky, R., Bennet, L.,
et al. (2017). Partial white and grey matter protection with prolonged infusion
of recombinant human erythropoietin after asphyxia in preterm fetal sheep.
J. Cereb. Blood Flow Metab. 37, 1080–1094. doi: 10.1177/0271678X16650455
Wegleiter, K., Hermann, M., Posod, A., Wechselberger, K., Stanika, R. I.,
Obermair, G. J., et al. (2014). The sigma-1 receptor agonist 4-phenyl-1-(4-
phenylbutyl) piperidine (PPBP) protects against newborn excitotoxic brain
injury by stabilizing the mitochondrial membrane potential in vitro and
inhibiting microglial activation in vivo. Exp. Neurol. 261, 501–509. doi: 10.1016/
j.expneurol.2014.07.022
Xia, Y., Xu, H., Jia, C., Hu, X., Kang, Y., Yang, X., et al. (2017). Tanshinone IIA
Attenuates Sevoflurane Neurotoxicity in Neonatal Mice. Anesth. Analg. 124,
1244–1252. doi: 10.1213/ANE.0000000000001942
Xie, C., Ginet, V., Sun, Y., Koike, M., Zhou, K., Li, T., et al. (2016). Neuroprotection
by selective neuronal deletion of Atg7 in neonatal brain injury. Autophagy 12,
410–423. doi: 10.1080/15548627.2015.1132134
Xiong, M., Zhang, L., Li, J., Eloy, J., Ye, J. H., and Bekker, A. (2016). Propofol-
induced neurotoxicity in the fetal animal brain and developments in modifying
these effects-an updated review of propofol fetal exposure in laboratory animal
studies. Brain Sci. 6:E11. doi: 10.3390/brainsci6020011
Xue, M., Balasubramaniam, J., Buist, R. J., Peeling, J., and Del Bigio, M. R. (2003).
Periventricular/intraventricular hemorrhage in neonatal mouse cerebrum.
J. Neuropathol. Exp. Neurol. 62, 1154–1165. doi: 10.1093/jnen/62.11.1154
Yavuz, A., Sezik, M., Ozmen, O., and Asci, H. (2017). Fingolimod against
endotoxin-induced fetal brain injury in a rat model. J. Obstet. Gynaecol. Res.
43, 1708–1713. doi: 10.1111/jog.13444
Yawno, T., Mahen, M., Li, J., Fahey, M. C., Jenkin, G., and Miller, S. L. (2017a).
The beneficial effects of melatonin administration following hypoxia-ischemia
in preterm fetal sheep. Front. Cell Neurosci. 11:296. doi: 10.3389/fncel.2017.
00296
Yawno, T., Sabaretnam, T., Li, J., McDonald, C., Lim, R., Jenkin, G., et al. (2017b).
Human amnion epithelial cells protect against white matter brain injury after
repeated endotoxin exposure in the preterm ovine fetus. Cell Transplant. 26,
541–553. doi: 10.3727/096368916X693572
Yesilirmak, D. C., Kumral, A., Baskin, H., Ergur, B. U., Aykan, S., Genc, S., et al.
(2007). Activated protein C reduces endotoxin-induced white matter injury in
the developing rat brain. Brain Res. 1164, 14–23. doi: 10.1016/j.brainres.2007.
04.083
Yis, U., Kurul, S. H., Kumral, A., Cilaker, S., Tugyan, K., Genc, S., et al. (2008a).
Hyperoxic exposure leads to cell death in the developing brain. Brain Dev. 30,
556–562. doi: 10.1016/j.braindev.2008.01.010
Yis, U., Kurul, S. H., Kumral, A., Tugyan, K., Cilaker, S., Yilmaz, O., et al. (2008b).
Effect of erythropoietin on oxygen-induced brain injury in the newborn rat.
Neurosci. Lett. 448, 245–249. doi: 10.1016/j.neulet.2008.10.060
Zheng, H., Dong, Y., Xu, Z., Crosby, G., Culley, D.J., Zhang, Y., et al..
(2013). Sevoflurane anesthesia in pregnant mice induces neurotoxicity in
fetal and offspring mice. Anesthesiology 118, 516–526. doi: 10.1097/ALN.
0b013e3182834d5d
Zhang, Z., Narayan, S., Su, L., Al-Alawyat, H., Liu, J., and Kannan, S.
(2018). Cerebellar injury and impaired function in a rabbit model of
maternal inflammation induced neonatal brain injury. Neurobiol. Learn. Mem.
165:106901. doi: 10.1016/j.nlm.2018.07.005
Zhu, J., Qu, Y., Lin, Z., Zhao, F., Zhang, L., Huang, Y., et al. (2016). Loss of
PINK1 inhibits apoptosis by upregulating alpha-synuclein in inflammation-
sensitized hypoxic-ischemic injury in the immature brains. Brain Res. 1653,
14–22. doi: 10.1016/j.brainres.2016.10.009
Zia, M. T., Csiszar, A., Labinskyy, N., Hu, F., Vinukonda, G., LaGamma, E. F., et al.
(2009). Oxidative-nitrosative stress in a rabbit pup model of germinal matrix
hemorrhage: role of NAD(P)H oxidase. Stroke 40, 2191–2198. doi: 10.1161/
STROKEAHA.108.544759
Zubiaurre-Elorza, L., Soria-Pastor, S., Junque, C., Segarra, D., Bargallo, N., Mayolas,
N., et al. (2011). Gray matter volume decrements in preterm children with
periventricular leukomalacia. Pediatr. Res. 69, 554–560. doi: 10.1203/PDR.
0b013e3182182366
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Truttmann, Ginet and Puyal. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 26 February 2020 | Volume 8 | Article 27
